Section 11

EurekaMag Full Text Articles Chapter 10,494


Dupraz, P.; Cottet, S.; Hamburger, F.; Dolci, W.; Felley Bosco, E.; Thorens, B. 2000: Dominant negative MyD88 proteins inhibit interleukin-1beta/interferon-gamma-mediated induction of nuclear factor kappaB-dependent nitrite production and apoptosis in beta cells. Journal of Biological Chemistry 275(48): 37672-37678
Chen, X.; Edwards, J.A.S.; Logsdon, C.D.; Ernst, S.A.; Williams, J.A. 2002: Dominant negative Rab3D inhibits amylase release from mouse pancreatic acini. Journal of Biological Chemistry 277(20): 18002-18009
Ding, W-Qun.; Kuntz, S.; Böhmig, M.; Wiedenmann, B.; Miller, L.J. 2002: Dominant negative action of an abnormal secretin receptor arising from mRNA missplicing in a gastrinoma. Gastroenterology 122(2): 500-511
Burgos-Trinidad, M.; Koenig, R.J. 1999: Dominant negative activity of thyroid hormone receptor variant alpha2 and interaction with nuclear corepressors. Molecular and Cellular Endocrinology 149(1-2): 107-114
Scherer-Oppliger, T.; Matasovic, A.; Laufs, S.; Levy, H.L.; Quackenbush, E.J.; Blau, N.; Thöny, B. 1999: Dominant negative allele (N47D) in a compound heterozygote for a variant of 6-pyruvoyltetrahydropterin synthase deficiency causing transient hyperphenylalaninemia. Human Mutation 13(4): 286-289
Ioroi, T.; Yamamori, M.; Yagi, K.; Hirai, M.; Zhan, Y.; Kim, S.; Iwao, H. 2003: Dominant negative c-Jun inhibits platelet-derived growth factor-directed migration by vascular smooth muscle cells. Journal of Pharmacological Sciences 91(2): 145-148
Hennigan, R.F.; Stambrook, P.J. 2001: Dominant negative c-jun inhibits activation of the cyclin D1 and cyclin e kinase complexes. Molecular Biology of the Cell 12(8): 2352-2363
Saadi, I.; Kuburas, A.; Engle, J.J.; Russo, A.F. 2003: Dominant negative dimerization of a mutant homeodomain protein in Axenfeld-Rieger syndrome. Molecular and Cellular Biology 23(6): 1968-1982
Yuan, Q.; Zhao, F.; Chung, S.W.; Fan, P.; Sultzer, B.M.; Kan, Y.W.; Wong, P.M. 2000: Dominant negative down-regulation of endotoxin-induced tumor necrosis factor alpha production by Lps(d)/Ran. Proceedings of the National Academy of Sciences of the United States of America 97(6): 2852-2857
Shimizu, R.; Komatsu, N.; Miura, Y. 1999: Dominant negative effect of a truncated erythropoietin receptor (EPOR-T) on erythropoietin-induced erythroid differentiation: Possible involvement of EPOR-T in ineffective erythropoiesis of myelodysplastic syndrome. Experimental Hematology 27(2): 229-233
Dihlmann, S.; Gebert, J.; Siermann, A.; Herfarth, C.; von Knebel Doeberitz, M. 1999: Dominant negative effect of the APC1309 mutation: a possible explanation for genotype-phenotype correlations in familial adenomatous polyposis. Cancer Research 59(8): 1857-1860
Bernard-Pierrot, I.; Delbé, J.; Rouet, V.; Vigny, M.; Kerros, M.-E.; Caruelle, D.èl.; Raulais, D.; Barritault, D.; Courty, J.é; Milhiet, P.E. 2002: Dominant negative effectors of heparin affin regulatory peptide (HARP) angiogenic and transforming activities. Journal of Biological Chemistry 277(35): 32071-32077
Buttini, M.; Akeefe, H.; Lin, C.; Mahley, R.W.; Pitas, R.E.; Wyss-Coray, T.; Mucke, L. 2000: Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease. Neuroscience 97(2): 207-210
Solomon, C.S.; Goalstone, M.L. 2001: Dominant negative farnesyltransferase alpha-subunit inhibits insulin mitogenic effects. Biochemical and Biophysical Research Communications 285(2): 161-166
Kotani, K.; Ogawa, W.; Hino, Y.; Kitamura, T.; Ueno, H.; Sano, W.; Sutherland, C.; Granner, D.K.; Kasuga, M. 1999: Dominant negative forms of Akt (protein kinase B) and atypical protein kinase Clambda do not prevent insulin inhibition of phosphoenolpyruvate carboxykinase gene transcription. Journal of Biological Chemistry 274(30): 21305-21312
Li, S.; Koromilas, A.E. 2001: Dominant negative function by an alternatively spliced form of the interferon-inducible protein kinase PKR. Journal of Biological Chemistry 276(17): 13881-13890
Zhu, C-Hong.; Domann, F.E. 2002: Dominant negative interference of transcription factor AP-2 causes inhibition of ErbB-3 expression and suppresses malignant cell growth. Breast Cancer Research and Treatment 71(1): 47-57
Kitayama, S.; Ikeda, T.; Mitsuhata, C.; Sato, T.; Morita, K.; Dohi, T. 1999: Dominant negative isoform of rat norepinephrine transporter produced by alternative RNA splicing. Journal of Biological Chemistry 274(16): 10731-10736
Nakase, K.; Ishimaru, F.; Avitahl, N.; Dansako, H.; Matsuo, K.; Fujii, K.; Sezaki, N.; Nakayama, H.; Yano, T.; Fukuda, S.; Imajoh, K.; Takeuchi, M.; Miyata, A.; Hara, M.; Yasukawa, M.; Takahashi, I.; Taguchi, H.; Matsue, K.; Nakao, S.; Niho, Y.; Takenaka, K.; Shinagawa, K.; Ikeda, K.; Niiya, K.; Harada, M. 2000: Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia. Cancer Research 60(15): 4062-4065
Belaguli, N.S.; Zhou, W.; Trinh, T.H.; Majesky, M.W.; Schwartz, R.J. 1999: Dominant negative murine serum response factor: alternative splicing within the activation domain inhibits transactivation of serum response factor binding targets. Molecular and Cellular Biology 19(7): 4582-4591
Miyamoto, A.; Matsuyama, S-ichi.; Tokuda, H. 2002: Dominant negative mutant of a lipoprotein-specific molecular chaperone, LolA, tightly associates with LolCDE. FEBS Letters 528(1-3): 193-196
Omura, T.; Yoshiyama, M.; Yoshida, K.; Nakamura, Y.; Kim, S.; Iwao, H.; Takeuchi, K.; Yoshikawa, J. 2002: Dominant negative mutant of c-Jun inhibits cardiomyocyte hypertrophy induced by endothelin 1 and phenylephrine. Hypertension 39(1): 81-86
Ilaria, R.L.; Hawley, R.G.; Van Etten, R.A. 1999: Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation. Blood 93(12): 4154-4166
Lin, R.; Canfield, V.; Levenson, R. 2002: Dominant negative mutants of filamin A block cell surface expression of the D2 dopamine receptor. Pharmacology 66(4): 173-181
Yuen, P.S. 1999: Dominant negative mutants of guanylyl cyclase: probes for global functions and intramolecular mechanisms. Methods 19(4): 532-544
Von Weizsäcker, F.; Köck, J.; Wieland, S.; Offensperger, W.B.; Blum, H.E. 1999: Dominant negative mutants of the duck hepatitis B virus core protein interfere with RNA pregenome packaging and viral DNA synthesis. Hepatology 30(1): 308-315
Edwalds-Gilbert, G.; Kim, D.H.; Kim, S.H.; Tseng, Y.H.; Yu, Y.; Lin, R.J. 2000: Dominant negative mutants of the yeast splicing factor Prp2 map to a putative cleft region in the helicase domain of DExD/H-box proteins. Rna 6(8): 1106-1119
Williams, D.A.; Tao, W.; Yang, F.; Kim, C.; Gu, Y.; Mansfield, P.; Levine, J.E.; Petryniak, B.; Derrow, C.W.; Harris, C.; Jia, B.; Zheng, Y.; Ambruso, D.R.; Lowe, J.B.; Atkinson, S.J.; Dinauer, M.C.; Boxer, L. 2000: Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency. Blood 96(5): 1646-1654
Barroso, I.; Gurnell, M.; Crowley, V.E.F.; Agostini, M.; Schwabe, J.W.; Soos, M.A.; Maslen, G.L.; Williams, T.D.M.; Lewis, H.; Schafer, A.J.; Chatterjee, V.K.K.; O'rahilly, S. 1999: Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature (London) 402(6764): 880-883, Dec 23-30
Leavitt, L.M.; Macaluso, C.R.; Kim, K.S.; Martin, N.P.; Dumont, M.E. 1999: Dominant negative mutations in the alpha-factor receptor, a G protein-coupled receptor encoded by the STE2 gene of the yeast Saccharomyces cerevisiae. Molecular and General Genetics: Mgg 261(6): 917-932
Zhu, X.; Hadhazy, M.; Wehling, M.; Tidball, J.G.; Mcnally, E.M. 2000: Dominant negative myostatin produces hypertrophy without hyperplasia in muscle. FEBS Letters 474(1): 71-75
Izumi, T.; Yokota-Hashimoto, H.; Zhao, S.; Wang, J.; Halban, P.A.; Takeuchi, T. 2003: Dominant negative pathogenesis by mutant proinsulin in the Akita diabetic mouse. Diabetes 52(2): 409-416
Ikeda, Y.; Taniguchi, N.; Noguchi, T. 2000: Dominant negative role of the glutamic acid residue conserved in the pyruvate kinase M(1) isozyme in the heterotropic allosteric effect involving fructose-1,6-bisphosphate. Journal of Biological Chemistry 275(13): 9150-9156
Clifford, J.L.; Yang, X.; Walch, E.; Wang, M.; Lippman, S.M. 2003: Dominant negative signal transducer and activator of transcription 2 (STAT2) protein: stable expression blocks interferon alpha action in skin squamous cell carcinoma cells. Molecular Cancer Therapeutics 2(5): 453-459
Coady, M.A.; Mandapati, D.; Arunachalam, B.; Jensen, K.; Maher, S.E.; Bothwell, A.L.; Hammond, G.L. 1999: Dominant negative suppression of major histocompatibility complex genes occurs in trophoblasts. Transplantation 67(11): 1461-1467
Sutton, P.; Kolesnikow, T.; Danon, S.; Wilson, J.; Lee, A. 2000: Dominant nonresponsiveness to Helicobacter pylori infection is associated with production of interleukin 10 but not gamma interferon. Infection and Immunity 68(8): 4802-4804
Johnston, R.L.; Seller, M.J.; Behnam, J.T.; Burdon, M.A.; Spalton, D.J. 1999: Dominant optic atrophy. Refining the clinical diagnostic criteria in light of genetic linkage studies. Ophthalmology 106(1): 123-128
Picard, F.; Baulac, S.; Kahane, P.; Hirsch, E.; Sebastianelli, R.; Thomas, P.; Vigevano, F.; Genton, P.; Guerrini, R.; Gericke, C.A.; An, I.; Rudolf, G.; Herman, A.; Brice, A.; Marescaux, C.; LeGuern, E. 2000: Dominant partial epilepsies. A clinical, electrophysiological and genetic study of 19 European families. Brain: a Journal of Neurology 123: 1247-1262
Russell, K.L.; Ming, J.E.; Patel, K.; Jukofsky, L.; Magnusson, M.; Krantz, I.D. 2001: Dominant paternal transmission of Cornelia de Lange syndrome: A new case and review of 25 previously reported familial recurrences. American Journal of Medical Genetics 104(4): 267-276
Trettel, F.; Rigamonti, D.; Hilditch-Maguire, P.; Wheeler, V.C.; Sharp, A.H.; Persichetti, F.; Cattaneo, E.; MacDonald, M.E. 2000: Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Human Molecular Genetics 9(19): 2799-2809
Matsumoto, M.; Traboulsi, E.I. 2001: Dominant radial drusen and Arg345Trp EFEMP1 mutation. American Journal of Ophthalmology 131(6): 810-812
Hussain, R.; Dockrell, H.M.; Chiang, T.J. 1999: Dominant recognition of a cross-reactive B-cell epitope in Mycobacterium leprae 10 K antigen by immunoglobulin G1 antibodies across the disease spectrum in leprosy. Immunology 96(4): 620-627
Cioffi, D.L.; Moore, T.M.; Schaack, J.; Creighton, J.R.; Cooper, D.M.F.; Stevens, T. 2002: Dominant regulation of interendothelial cell gap formation by calcium-inhibited type 6 adenylyl cyclase. Journal of Cell Biology 157(7): 1267-1278
Honey, K.; Cobbold, S.P.; Waldmann, H. 1999: Dominant regulation: a common mechanism of monoclonal antibody induced tolerance?. Immunologic Research 20(1): 1-14
Imao, T.; Koshida, K.; Endo, Y.; Uchibayashi, T.; Sasaki, T.; Namiki, M. 1999: Dominant role of E-cadherin in the progression of bladder cancer. Journal of Urology 161(2): 692-698
Martin, S.; van den Engel, N.K.; Vinke, A.; Heidenthal, E.; Schulte, B.; Kolb, H. 2001: Dominant role of intercellular adhesion molecule-1 in the pathogenesis of autoimmune diabetes in non-obese diabetic mice. Journal of Autoimmunity 17(2): 109-117
Ledvina, P.S.; Tsai, A.L.; Wang, Z.; Koehl, E.; Quiocho, F.A. 1998: Dominant role of local dipolar interactions in phosphate binding to a receptor cleft with an electronegative charge surface: equilibrium, kinetic, and crystallographic studies. Protein Science: a Publication of the Protein Society 7(12): 2550-2559
Bukovsky, A.; Caudle, M.R.; Keenan, J.A. 2000: Dominant role of monocytes in control of tissue function and aging. Medical Hypotheses 55(4): 337-347
Jolimay, N.; Franck, L.; Langlois, X.; Hamon, M.; Darmon, M. 2000: Dominant role of the cytosolic C-terminal domain of the rat 5-HT1B receptor in axonal-apical targeting. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 20(24): 9111-9118
Brown, L.R.; Deng, J.; Clarke, N.D. 2000: Dominant sensitization variants of human O(6)-methylguanine-DNA-methyltransferase obtained by a mutational screen of surface residues. Mutation Research 459(1): 81-87
Naumenko, Y.V. 1998: Dominant species of the phytoplancton of the Ob river. Botanicheskii Zhurnal (St Petersburg) 83(10): 35-41
Skrzypek, M.; Lester, R.L.; Spielmann, P.; Zingg, N.; Shelling, J.; Dickson, R.C. 2000: Dominant suppressor mutation bypasses the sphingolipid requirement for growth of Saccharomyces cells at low pH: Role of the CWP2 gene. Current Genetics 38(4): 191-201
Honey, K.; Cobbold, S.P.; Waldmann, H. 2000: Dominant tolerance and linked suppression induced by therapeutic antibodies do not depend on Fas-FasL interactions. Transplantation 69(8): 1683-1689
Stelling, J.R.; Gray, M.R.; Davis, A.J.; Cowan, J.M.; Reindollar, R.H. 2000: Dominant transmission of imperforate hymen. Fertility and Sterility 74(6): 1241-1244
Haberman, J. 2000: Dominant zooplankton species in Lake Peipsi. Proceedings of the Estonian Academy of Sciences Biology Ecology 49(1): 34-51
Notidis, E.; Heltemes, L.; Manser, T. 2002: Dominant, hierarchical induction of peripheral tolerance during foreign antigen-driven B cell development. Immunity 17(3): 317-327
Yeh, J.H.; Sun, M.H.; Chiu, H.C. 1999: Dominant-inherited hypokalemic periodic paralysis in a large Chinese family. Journal of the Formosan Medical Association 98(4): 277-282
Anders, K.R.; Botstein, D. 2001: Dominant-lethal alpha-tubulin mutants defective in microtubule depolymerization in yeast. Molecular Biology of the Cell 12(12): 3973-3986
Vizirianakis, I.S.; Chen, Y-Qi.; Kantak, S.S.; Tsiftsoglou, A.S.; Kramer, R.H. 2002: Dominant-negative E-cadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cells. International Journal of Oncology 21(1): 135-144
Andreucci, A.; Reeves, R.; McCarthy, K.M.; Nikolajczyk, B.S. 2002: Dominant-negative HMGA1 blocks mu enhancer activation through a novel mechanism. Biochemical and Biophysical Research Communications 292(2): 427-433
Abbas, S.; Abu-Amer, Y. 2003: Dominant-negative IkappaB facilitates apoptosis of osteoclasts by tumor necrosis factor-alpha. Journal of Biological Chemistry 278(22): 20077-20082
Lee, Y.J.; Galoforo, S.S.; Sim, J.E.; Ridnour, L.A.; Choi, J.; Forman, H.J.; Corry, P.M.; Spitz, D.R. 2000: Dominant-negative Jun N-terminal protein kinase (JNK-1) inhibits metabolic oxidative stress during glucose deprivation in a human breast carcinoma cell line. Free Radical Biology and Medicine 28(4): 575-584
Stewart, B.A.; Mohtashami, M.; Rivlin, P.; Deitcher, D.L.; Trimble, W.S.; Boulianne, G.L. 2002: Dominant-negative NSF2 disrupts the structure and function of Drosophila neuromuscular synapses. Journal of Neurobiology 51(4): 261-271
Akeda, Y.; Kodama, T.; Kashimoto, T.; Cantarelli, V.; Horiguchi, Y.; Nagayama, K.; Iida, T.; Honda, T. 2002: Dominant-negative Rho, Rac, and Cdc42 facilitate the invasion process of Vibrio parahaemolyticus into Caco-2 cells. Infection and Immunity 70(2): 970-973
Hoodless, P.A.; Tsukazaki, T.; Nishimatsu, S.; Attisano, L.; Wrana, J.L.; Thomsen, G.H. 1999: Dominant-negative Smad2 mutants inhibit activin/Vg1 signaling and disrupt axis formation in Xenopus. Developmental Biology 207(2): 364-379
Leaños-Miranda, A.; Ulloa-Aguirre, A.; Ji, T.H.; Janovick, J.Ann.; Conn, P.Michael. 2003: Dominant-negative action of disease-causing gonadotropin-releasing hormone receptor (GnRHR) mutants: a trait that potentially coevolved with decreased plasma membrane expression of GnRHR in humans. Journal of Clinical Endocrinology and Metabolism 88(7): 3360-3367
Sylvain, V.; Lafarge, S.; Bignon, Y-Jean. 2002: Dominant-negative activity of a Brca1 truncation mutant: effects on proliferation, tumorigenicity in vivo, and chemosensitivity in a mouse ovarian cancer cell line. International Journal of Oncology 20(4): 845-853
Chen, S.; Lin, F.; Xu, M.; Hwa, J.; Graham, R.M. 2000: Dominant-negative activity of an alpha(1B)-adrenergic receptor signal-inactivating point mutation. EMBO Journal 19(16): 4265-4271
Roth, D.; Birkenfeld, J.; Betz, H. 1999: Dominant-negative alleles of 14-3-3 proteins cause defects in actin organization and vesicle targeting in the yeast Saccharomyces cerevisiae. FEBS Letters 460(3): 411-416
Whitfield, J.; Neame, S.J.; Paquet, L.; Bernard, O.; Ham, J. 2001: Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release. Neuron 29(3): 629-643
Amorino, G.P.; Mikkelsen, R.B.; Valerie, K.; Schmidt-Ullrich, R.K. 2003: Dominant-negative cAMP-responsive element-binding protein inhibits proliferating cell nuclear antigen and DNA repair, leading to increased cellular radiosensitivity. Journal of Biological Chemistry 278(32): 29394-29399
Kage, K.; Tsukahara, S.; Sugiyama, T.; Asada, S.; Ishikawa, E.; Tsuruo, T.; Sugimoto, Y. 2002: Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization. International Journal of Cancer 97(5): 626-630
Lee, A.; Frank, D.W.; Marks, M.S.; Lemmon, M.A. 1999: Dominant-negative inhibition of receptor-mediated endocytosis by a dynamin-1 mutant with a defective pleckstrin homology domain. Current Biology: Cb 9(5): 261-264
Belecz, I.; Gonzalez, C.; Puro, J.; Szabad, J. 2001: Dominant-negative mutant dynein allows spontaneous centrosome assembly, uncouples chromosome and centrosome cycles. Current Biology: Cb 11(2): 136-140
Shinotsuka, C.; Waguri, S.; Wakasugi, M.; Uchiyama, Y.; Nakayama, K. 2002: Dominant-negative mutant of BIG2, an ARF-guanine nucleotide exchange factor, specifically affects membrane trafficking from the trans-Golgi network through inhibiting membrane association of AP-1 and GGA coat proteins. Biochemical and Biophysical Research Communications 294(2): 254-260
Bae, T.; Dunny, G.M. 2001: Dominant-negative mutants of prgX: Evidence for a role for PrgX dimerization in negative regulation of pheromone-inducible conjugation. Molecular Microbiology 39(5): 1307-1320
Schweisguth, F. 1999: Dominant-negative mutation in the beta2 and beta6 proteasome subunit genes affect alternative cell fate decisions in the Drosophila sense organ lineage. Proceedings of the National Academy of Sciences of the United States of America 96(20): 11382-11386
Sakuragi, N.; Hirai, A.; Tada, M.; Yamada, H.; Yamamoto, R.; Fujimoto, S.; Moriuchi, T. 2001: Dominant-negative mutation of p53 tumor suppressor gene in endometrial carcinoma. Gynecologic Oncology 83(3): 485-490
Marutani, M.; Tonoki, H.; Tada, M.; Takahashi, M.; Kashiwazaki, H.; Hida, Y.; Hamada, J.; Asaka, M.; Moriuchi, T. 1999: Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme. Cancer Research 59(19): 4765-4769
Morrison, A.J.; Herrera, R.E.; Heinsohn, E.C.; Schiff, R.; Osborne, C.K. 2003: Dominant-negative nuclear receptor corepressor relieves transcriptional inhibition of retinoic acid receptor but does not alter the agonist/antagonist activities of the tamoxifen-bound estrogen receptor. Molecular Endocrinology 17(8): 1543-1554
Han, Z.; Boyle, D.L.; Shi, Y.; Green, D.R.; Firestein, G.S. 1999: Dominant-negative p53 mutations in rheumatoid arthritis. Arthritis and Rheumatism 42(6): 1088-1092
Er, F.; Larbig, R.; Ludwig, A.; Biel, M.; Hofmann, F.; Beuckelmann, D.J.; Hoppe, U.C. 2003: Dominant-negative suppression of HCN channels markedly reduces the native pacemaker current I(f) and undermines spontaneous beating of neonatal cardiomyocytes. Circulation 107(3): 485-489
Xue, T.; Marbán, E.; Li, R.A. 2002: Dominant-negative suppression of HCN1- and HCN2-encoded pacemaker currents by an engineered HCN1 construct: insights into structure-function relationships and multimerization. Circulation Research 90(12): 1267-1273
McLerie, M.; Lopatin, A.N.; Lopatin, A. 2003: Dominant-negative suppression of I(K1) in the mouse heart leads to altered cardiac excitability. Journal of Molecular and Cellular Cardiology 35(4): 367-378
Raghib, A.; Bertaso, F.; Davies, A.; Page, K.M.; Meir, A.; Bogdanov, Y.; Dolphin, A.C. 2001: Dominant-negative synthesis suppression of voltage-gated calcium channel Cav2.2 induced by truncated constructs. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 21(21): 8495-8504
Li, F.; Szobor, A.; Croxen, R.; Anselmo, V.; Yuan, Q.P.; Lindblad, K.; Schalling, M.; Komoly, S.; Beeson, D.; Larsson, C. 2001: Dominantly inherited familial myasthenia gravis as a separate genetic entity without involvement of defined candidate gene loci. International Journal of Molecular Medicine 7(3): 289-294
Huopio, H.; Reimann, F.; Ashfield, R.; Komulainen, J.; Lenko, H.L.; Rahier, J.; Vauhkonen, I.; Kere, J.; Laakso, M.; Ashcroft, F.; Otonkoski, T. 2000: Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1. Journal of Clinical Investigation 106(7): 897-906
Müller, H.D.; Vielhaber, S.; Brunn, A.; Schröder, J.M. 2001: Dominantly inherited myopathy with novel tubular aggregates containing 1-21 tubulofilamentous structures. Acta Neuropathologica 102(1): 27-35
Vallat, J.-M. 2003: Dominantly inherited peripheral neuropathies. Journal of Neuropathology and Experimental Neurology 62(7): 699-714
Spangfort, M.D.; Mirza, O.; Ipsen, H.; Van Neerven, R.J.J.; Gajhede, M.; Larsen, J.ør.N. 2003: Dominating IgE-binding epitope of Bet v 1, the major allergen of birch pollen, characterized by X-ray crystallography and site-directed mutagenesis. Journal of Immunology 171(6): 3084-3090
Frisk, A.L.; Baumgärtner, W.; Gröne, A. 1999: Dominating interleukin-10 mRNA expression induction in cerebrospinal fluid cells of dogs with natural canine distemper virus induced demyelinating and non-demyelinating CNS lesions. Journal of Neuroimmunology 97(1-2): 102-109
Donckier, V.; El Nakadi, I.; Closset, J.; Ickx, B.; Louis, H.; Le Moine, O.; Bourgeois, N.; Adler, M.; Gelin, M. 2001: Domino hepatic transplantation using the liver from a patient with primary hyperoxaluria. Transplantation 71(9): 1346-1348
Nishizaki, T.; Kishikawa, K.; Yoshizumi, T.; Uchiyama, H.; Okano, S.; Ikegami, T.; Hashimoto, K.; Nomoto, K.; Shimada, M.; Yanaga, K.; Takenaka, K.; Sugimachi, K.; Ando, Y.; Ando, M. 2000: Domino liver transplantation from a living related donor. Transplantation 70(8): 1236-1239
Arjona, Oón.; Csákÿ, A.G.; Medel, Río.; Plumet, Jín. 2002: Domino metathesis of 2-azanorbornenones: a new strategy for the enatioselective synthesis of 1-azabicyclic compounds. Journal of Organic Chemistry 67(4): 1380-1383
Nötzel, M.W.; Rauch, K.; Labahn, T.; de Meijere, A. 2002: Domino reactions of amidines with methyl 2-chloro-2-cyclopropylideneacetate as an efficient access to cyclobutene-annelated pyrimidinones. Organic Letters 4(5): 839-841
Macphee, R.; Iturralde Vinent, M.; Gaffney, E.S. 2003: Domo de Zaza, an Early Miocene vertebrate locality in south-central Cuba, with notes on the tectonic evolution of Puerto Rico and the Mona Passage. American Museum: 1-42
Vale, P.; Sampayo, M.A. 2001: Domoic acid in Portuguese shellfish and fish. Toxicon: Official Journal of the International Society on Toxinology 39(6): 893-904
Lefebvre, K.; Silver, M.; Coale, S.; Tjeerdema, R. 2002: Domoic acid in planktivorous fish in relation to toxic Pseudo-nitzschia cell densities. ine Biology Berlin ch; 140(3): 625-631
Cheng, Z.; Guo, S.Z.; Lipton, A.J.; Gozal, D. 2002: Domoic acid lesions in nucleus of the solitary tract: time-dependent recovery of hypoxic ventilatory response and peripheral afferent axonal plasticity. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 22(8): 3215-3226
Berman, F.W.; Lepage, K.T.; Murray, T.F. 2002: Domoic acid neurotoxicity in cultured cerebellar granule neurons is controlled preferentially by the NMDA receptor Ca2+ influx pathway. Brain Research 924(1): 20-29, 4 January
Kotaki, Y.ichi; Koike, Kazuhiko; Yoshida, Makoto; Thuoc, Chu-Van; Huyen, Nguyen-Thi-Minh; Hoi, Nguyen-Chu; Fukuyo, Yasuwo; Kodama, Masaaki 2000: Domoic acid production in Nitzschia sp. (Bacillariophyceae) isolated from a shrimp-culture pond in Do Son, Vietnam. Journal of Phycology 36(6): 1057-1060
Trainer, V.L.; Adams, N.G.; Bill, B.D.; Stehr, C.M.; Wekell, J.C.; Moeller, P.; Busman, M.; Woodruff, D. 2000: Domoic acid production near California coastal upwelling zones, June 1998. Limnology and Oceanography 45(8): 1818-1833
Sari, P.; Kerr, D.S. 2001: Domoic acid-induced hippocampal CA1 hyperexcitability independent of region CA3 activity. Epilepsy Research 47(1-2): 65-76
Nijjar, M.S.; Nijjar, S.S. 2000: Domoic acid-induced neurodegeneration resulting in memory loss is mediated by Ca2+ overload and inhibition of Ca2+ + calmodulin-stimulated adenylate cyclase in rat brain (review). International Journal of Molecular Medicine 6(4): 377-389
Ananth, C.; Thameem Dheen, S.; Gopalakrishnakone, P.; Kaur, C. 2001: Domoic acid-induced neuronal damage in the rat hippocampus: Changes in apoptosis related genes (Bcl-2, Bax, Caspase-3) and microglial response. Journal of Neuroscience Research 66(2): 177-190
Mos, L. 2001: Domoic acid: A fascinating marine toxin. Environmental Toxicology and Pharmacology 9(3): 79-85
Franzese, A.; Borrelli, O.; Corrado, G.; Rea, P.; Di Nardo, G.; Grandinetti, A.L.; Dito, L.; Cucchiara, S. 2002: Domperidone is more effective than cisapride in children with diabetic gastroparesis. Alimentary Pharmacology and Therapeutics 16(5): 951-957
Drolet, B.; Rousseau, G.; Daleau, P.; Cardinal, R.; Turgeon, J. 2000: Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. Circulation 102(16): 1883-1885
Wang De Shou; Lin Hao Ran; Pu De Yong; Zhang Yao Guang; Zhang Qi Zhong; He Xue Fu; Jiang Guo Fu 1998: Domperidone-LHRH-A-induced ovulation of the bagrid catfish, Mystus macropterus and Leiocassis longirostris. Zoological Research 19(3): 191-196
Barone, J.A. 1999: Domperidone: A peripherally acting dopamine2-receptor antagonist. Annals of Pharmacotherapy 33(4): 429-440
Brodsky, S.L.; Lichtenstein, B. 1999: Don't ask questions: a psychotherapeutic strategy for treatment of involuntary clients. American Journal of PsychoTherapy 53(2): 215-220
Ubel, P.A.; Jepson, C.; Silver-Isenstadt, A. 2003: Don't ask, don't tell: A change in medical student attitudes after obstetrics/gynecology clerkships toward seeking consent for pelvic examinations on an anesthetized patient. American Journal of Obstetrics and Gynecology 188(2): 575-579
Menke, D.; Fiedler, H.; Zwahr, H. 2003: Don't ban PVC: incinerate and recycle it instead!. Waste Management and Research: the Journal of the International Solid Wastes and Public Cleansing Association Iswa 21(2): 172-177
Evans, D.E.; Sheehan, M., C. 2002: Don't be fobbed off: The substance of beer foam: A review. Journal of the American Society of Brewing Chemists 60(2): 47-57
Hart, R.; Magos, A.; Nagele, F.; Heal, K.; Isorna, V.; Jirecek, S.; Kudielka, I. 1998: 'Don't be fooled by the patient's make-up'!. Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 18(6): 561-563
Field, S.A.; Calbert, G. 1999: Don't count your eggs before they're parasitized: Contest resolution and the trade-offs during patch defense in a parasitoid wasp. Behavioral Ecology 10(2): 122-127
Goldmeier, D.; Greene, L. 2002: Don't forget syphilis. Access to services for genitourinary medicine needs to be made easier. Bmj 325(7367): 775
Clark, P.; Cook, P.A.; Lighton, L.; Syed, Q.; Bellis, M.A. 2002: Don't forget syphilis. Syphilis outbreak is twice as big as reported. Bmj 325(7367): 775
Remer, T.; Manz, F. 2001: Don't forget the acid base status when studying metabolic and clinical effects of dietary potassium depletion. Journal of Clinical Endocrinology and Metabolism 86(12): 5996-5997
Logan, G.D.; Irwin, D.E. 2000: Don't look! Don't touch! Inhibitory control of eye and hand movements. Psychonomic Bulletin and Review 7(1): 107-112
Mehta, A.C. 2002: Don't lose the forest for the trees: satisfaction and success in bronchoscopy. American Journal of Respiratory and Critical Care Medicine 166(10): 1306-1307
Newble, D.I. 2002: Don't presume about experienced adult learners in medicine. Bmj 325(7367): 779
Al-Shahi, R.; Kennard, C. 2002: Don't slip through the net. Journal of Neurology Neurosurgery and Psychiatry 73(6): 611
Baselga, A.; Novoa, F. 2002: Donacia galaica Baguena, 1959, a little known species from Northwest of the Iberic peninsula (Coleoptera, Chrysomelidae). Nouvelle Revue d'Entomologie 19(3): 229-233
Martin, Aés.; Cohen, D.J. 2002: Donald J. Cohen, M.D., 1940-2001. American journal of psychiatry 159(11): 1829
Hoff, J.T.; Reis, D.J. 2003: Donald J. Reis, MD: Research mentor extraordinaire. Cellular and Molecular Neurobiology 23(4-5): 457-461
Talman, W.T. 2001: Donald Jeffrey Reis, MD: September 9, 1931-November 1, 2000. Hypertension 37(3): 825-826
Gruber, S.H. 2001: Donald Richard Nelson: The most unforgettable character I ever met. Environmental Biology of Fishes 60(1-3): 19-27
Zhang, D.Y.; Sun, G.J.; Jiang, X.H. 1999: Donald's ideotype and growth redundancy: A game theoretical analysis. Field Crops Research 61(2): 179-187
Luna-Zaragoza, D.; Reyes-Frías, M.L. 2001: Donation transplants and tissue banking in Mexico. Cell and Tissue Banking 2(4): 255-259
Medendorp, W.P.; van Gisbergen, J.A.; Horstink, M.W.; Gielen, C.C. 1999: Donders' law in torticollis. Journal of Neurophysiology 82(5): 2833-2838
Yesavage, J.A.; Mumenthaler, M.S.; Taylor, J.L.; Friedman, L.; O'Hara, R.; Sheikh, J.; Tinklenberg, J.; Whitehouse, P.J. 2002: Donepezil and flight simulator performance: effects on retention of complex skills. Neurology 59(1): 123-125
Wolfson, C.; Oremus, M.; Shukla, V.; Momoli, F.; Demers, L.; Perrault, A.; Moride, Y. 2002: Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness. Clinical Therapeutics 24(6): 862-86; discussion 837
Bergman, J.; Brettholz, I.; Shneidman, M.; Lerner, V. 2003: Donepezil as add-on treatment of psychotic symptoms in patients with dementia of the Alzheimer's type. Clinical Neuropharmacology 26(2): 88-92
Kasa, P.; Papp, H.; Kasa, P.; Torok, I. 2000: Donepezil dose-dependently inhibits acetylcholinesterase activity in various areas and in the presynaptic cholinergic and the postsynaptic cholinoceptive enzyme-positive structures in the human and rat brain. Neuroscience 101(1): 89-100
Kishnani, P.S.; Spiridigliozzi, G.A.; Heller, J.H.; Sullivan, J.A.; Doraiswamy, P.M.; Krishnan, K.R. 2001: Donepezil for Down's syndrome. American Journal of Psychiatry 158(1): 143
Noyan, M.Aysin.; Elbi, H.; Aksu, H. 2003: Donepezil for anticholinergic drug intoxication: A case report. Progress in Neuro-Psychopharmacology and Biological Psychiatry 27(5): 885-887
Lanctôt, K.L.; Herrmann, N. 2000: Donepezil for behavioural disorders associated with Lewy bodies: A case series. International Journal of Geriatric Psychiatry 15(4): 338-345
Aarsland, D.; Laake, K.; Larsen, J.P.; Janvin, C. 2002: Donepezil for cognitive impairment in Parkinson's disease: A randomised controlled study. Journal of Neurology Neurosurgery and Psychiatry 72(6): 708-712
Howard, A.K.; Thornton, A.E.; Altman, S.; Honer, W.G. 2002: Donepezil for memory dysfunction in schizophrenia. Journal of Psychopharmacology 16(3): 267-270
Jacobsen, F.M.; Comas-Díaz, L. 1999: Donepezil for psychotropic-induced memory loss. Journal of Clinical Psychiatry 60(10): 698-704
Barak, Y.; Bodner, E.; Zemishlani, H.; Mirecki, I.; Aizenberg, D. 2001: Donepezil for the treatment of behavioral disturbances in Alzheimer's disease: A 6-month open trial. Archives of Gerontology and Geriatrics 33(3): 237-241
Paleacu, D.; Mazeh, D.; Mirecki, I.; Even, M.; Barak, Y. 2002: Donepezil for the treatment of behavioral symptoms in patients with Alzheimer's disease. Clinical Neuropharmacology 25(6): 313-317
Heller, J.H.; Spiridigliozzi, G.A.; Sullivan, J.A.; Doraiswamy, P.M.; Krishnan, R.R.; Kishnani, P.S. 2003: Donepezil for the treatment of language deficits in adults with down syndrome: a preliminary 24-week open trial. American Journal of Medical Genetics. Part a 116a (2): 111-116
Nakano, S.; Asada, T.; Matsuda, H.; Uno, M.; Takasaki, M. 2001: Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 42(10): 1441-1445
Matthews, H.P.; Korbey, J.; Wilkinson, D.G.; Rowden, J. 2000: Donepezil in Alzheimer's disease: Eighteen month results from Southampton memory clinic. International Journal of Geriatric Psychiatry 15(8): 713-720
Rocca, P.; Cocuzza, E.; Marchiaro, L.; Bogetto, F. 2002: Donepezil in the treatment of Alzheimer's disease: Long-term efficacy and safety. Progress in Neuro-Psychopharmacology and Biological Psychiatry 26(2): 369-373
Fabbrini, G.; Barbanti, P.; Aurilia, C.; Pauletti, C.; Lenzi, G.L.; Meco, G. 2002: Donepezil in the treatment of hallucinations and delusions in Parkinson's disease. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 23(1): 41-43
Fabbrini, G.; Barbanti, P.; Bonifati, V.; Colosimo, C.; Gasparini, M.; Vanacore, N.; Meco, G. 2001: Donepezil in the treatment of progressive supranuclear palsy. Acta Neurologica Scandinavica 103(2): 123-125
Burt, T.; Sachs, G.S.; Demopulos, C. 1999: Donepezil in treatment-resistant bipolar disorder. Biological Psychiatry 45(8): 959-964
Wilkinson, D.; Doody, R.; Helme, R.; Taubman, K.; Mintzer, J.; Kertesz, A.; Pratt, R.D. 2003: Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology 61(4): 479-486
Geldmacher, D.S.; Provenzano, G.; Mcrae, T.; Mastey, V.; Ieni, J.R. 2003: Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease. Journal of the American Geriatrics Society 51(7): 937-944
Stryjer, R.; Bar, F.; Strous, R.D.; Baruch, Y.; Rabey, J.M. 2002: Donepezil management of schizophrenia with associated dementia. Journal of Clinical Psychopharmacology 22(2): 226-229
Shepherd, G.; Klein-Schwartz, W.; Edwards, R. 1999: Donepezil overdose: A tenfold dosing error. Annals of Pharmacotherapy 33(7-8): 812-815
Higgins, G.A.; Enderlin, M.; Fimbel, R.; Haman, M.; Grottick, A.J.; Soriano, M.; Richards, J.G.; Kemp, J.A.; Gill, R. 2002: Donepezil reverses a mnemonic deficit produced by scopolamine but not by perforant path lesion or transient cerebral ischaemia. European Journal of Neuroscience 15(11): 1827-1840
Greenberg, S.M.; Tennis, M.K.; Brown, L.B.; Gomez-Isla, T.; Hayden, D.L.; Schoenfeld, D.A.; Walsh, K.L.; Corwin, C.; Daffner, K.R.; Friedman, P.; Meadows, M.E.; Sperling, R.A.; Growdon, J.H. 2000: Donepezil therapy in clinical practice: a randomized crossover study. Archives of Neurology 57(1): 94-99
Onofrj, M.; Thomas, A.; Luciano, A.Lisa.; Iacono, D.; Di Rollo, A.; D'Andreamatteo, G.; Di Iorio, A. 2002: Donepezil versus vitamin E in Alzheimer's disease: Part 2: mild versus moderate-severe Alzheimer's disease. Clinical Neuropharmacology 25(4): 207-215
Ogura, H.; Kosasa, T.; Kuriya, Y.; Yamanishi, Y. 2000: Donepezil, a centrally acting acetylcholinesterase inhibitor, alleviates learning deficits in hypocholinergic models in rats. Methods and Findings in Experimental and Clinical Pharmacology 22(2): 89-95
Thomas, A.; Iacono, D.; Bonanni, L.; D'Andreamatteo, G.; Onofrj, M. 2001: Donepezil, rivastigmine, and vitamin E in Alzheimer disease: a combined P300 event-related potentials/neuropsychologic evaluation over 6 months. Clinical Neuropharmacology 24(1): 31-42
Schredl, M.; Weber, B.; Leins, M.L.; Heuser, I. 2001: Donepezil-induced REM sleep augmentation enhances memory performance in elderly, healthy persons. Experimental Gerontology 36(2): 353-361
Poletaev, V.I. 2000: Donispirifer and Tegulispirifer: New Middle to Late Carboniferous spiriferids from Eurasia. Paleontologiceskij Zurnal (3): 50-57
Letienne, R.; Verscheure, Y.; Perez, M.; Le Grand, B.; Colpaert, F.C.; John, G.W. 2003: Donitriptan selectively decreases jugular venous oxygen saturation in the anesthetized pig: further insights into its mechanism of action relevant to headache relief. Journal of Pharmacology and Experimental Therapeutics 305(2): 749-754
Kleist, G.; Seehann, G. 1999: Donkioporia expansa - A lesser known wood destroyer in buildings. Zeitschrift fuer Mykologie 65(1): 23-32
Chassaing, N.; Lacombe, D.; Carles, D.; Calvas, P.; Saura, R.; Bieth, E. 2003: Donnai-Barrow syndrome: four additional patients. American Journal of Medical Genetics. Part a 121a (3): 258-262
Mougin, J.L.; Mougin, M.C. 2000: Donnees complementaires sur la plongee du Puffin cendre Calonectris diomedea de Selvagem Grande (30degree 09' N, 15degree 52' W). Boletim do Museu Municipal do Funchal 52: 37-44
Essalmani, R.; Soulier, S.; Besnard, N.; Hudrisier, M.; Costa-Da-Silva, J.; Vilotte, J.L. 2000: Donnees de base sur la transgenese. Productions Animales (Paris) (Special Issue): 181-186
Fruchart, J.C.; Duriez, P. 2001: Donnees fondamentales sur l'atherosclerose. Annales d'Endocrinologie 62(1 Part 2): 93-100
Jorda, M.; Rosique, T.; Evin, J. 2000: Donnees nouvelles sur l'age du dernier maximum glaciaire dans les Alpes meridionales francaises. Comptes Rendus de l'Academie des Sciences Serie II A Sciences de la Terre et des Planetes 331(3): 187-193
Selmi, S. 2000: Donnees nouvelles sur les avifaunes des Oasis du Sud Tunisien. Alauda 68(3): 201-212
Brustel, H.; Freeman, J.-Cyril; Valladares, L.; Van-Meer, C. 2001: Donnees originales sur quelques Cerambycidae des Pyrenees et regions voisines (Coleoptera). Bulletin de la Societe Linneenne de Bordeaux 29(1): 11-20
Moulard, B.; Crespel, A.; Malafosse, A.; Baldy-Moulinier, M. 2000: Donnees recentes sur la genetique des epilepsies idiopathiques et des convulsions febriles. Revue Neurologique (Paris) 156(10): 707-716
Duyckaerts, C.; Verny, M.; Hauw, J.J. 2003: Donnees recentes sur la neuropathologie des syndromes parkinsoniens. Revue Neurologique (Paris) 159(5 Part 2): 3S11-3S18
Duchateau, S.; Bounine, E.; Delage, F. 2003: Donnees sur le comportement de l'elanion blanc Elanus caeruleus en periode de reproduction en Aquitaine (France). Alauda 71(1): 9-30
Asselbergs, Jan, E.F. 2000: Donnees sur les captures recentes dans le sud-ouest de l'Europe de Pseudacrobasis nankingella Roesler, 1975, phycite originaire de l'Extreme-Orient (Lepidoptera, Pyralidae, Phycitinae). Alexanor 21(7-8): 491-494
Villard, P.; Thibault, J.C.aude 2001: Donnees sur les nids, la croissance des poussins et les soins parentaux chez la Sittelle corse Sitta whiteheadi. Alauda 69(4): 465-474
Montuschi, O. 2002: Donor Conception Network always advises openness. BMJ 324(7349): 1339
Beige, J.; Engeli, S.; Ringel, J.; Offermann, G.; Distler, A.; Sharma, A.M. 1999: Donor G protein beta3 subunit 825TT genotype is associated with reduced kidney allograft survival. Journal of the American Society of Nephrology: Jasn 10(8): 1717-1721
Shi, C.; Feinberg, M.W.; Zhang, D.; Patel, A.; Sim, C.U.; Dong, Z.M.; Chapman, S.M.; Gutierrez-Ramos, J.C.; Wagner, D.D.; Sibinga, N.E.; Haber, E. 1999: Donor MHC and adhesion molecules in transplant arteriosclerosis. Journal of Clinical Investigation 103(4): 469-474
Benza, R.L.; Anderson, P.G.; Lyle, K.; Barchue, J.; de Oliveira, A.Luna.; Cavender, M.A.; Pinderski, L.J.; George, J.F. 2003: Donor PAI-1 expression inhibits the intimal response of early allograft vascular disease. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 22(5): 515-518
Zhang, Z.; Kaptanoglu, L.; Haddad, W.; Ivancic, D.; Alnadjim, Z.; Hurst, S.; Tishler, D.; Luster, A.D.; Barrett, T.A.; Fryer, J. 2002: Donor T cell activation initiates small bowel allograft rejection through an IFN-gamma-inducible protein-10-dependent mechanism. Journal of Immunology 168(7): 3205-3212
Hummel, S.; Wilms, D.; Vitacolonna, M.; Zöller, M. 2002: Donor T cell and host NK depletion improve the therapeutic efficacy of allogeneic bone marrow cell reconstitution in the nonmyeloablatively conditioned tumor-bearing host. Journal of Leukocyte Biology 72(5): 898-912
Umemura, A.; Monaco, A.P.; Maki, T. 2000: Donor T cells are not required for induction of allograft tolerance in mice treated with antilymphocyte serum, rapamycin, and donor bone marrow cells. Transplantation 70(7): 1005-1009
Jiang, Z.; Podack, E.M.; Levy, R.B. 1998: Donor T cells which cannot mediate perforin dependent and FasL-dependent cytotoxicity can effect graft vs. Host reactivity following allogeneic bone marrow transplantation. Periodicum Biologorum 100(4): 477-481
Lee, T.H.; Reed, W.; Mangawang-Montalvo, L.; Watson, J.; Busch, M.P. 2001: Donor WBCs can persist and transiently mediate immunologic function in a murine transfusion model: effects of irradiation, storage, and histocompatibility. Transfusion 41(5): 637-642
Moreso, F.; Serón, D.; Gil-Vernet, S.; Riera, L.; Fulladosa, X.; Ramos, R.; Alsina, J.; Grinyó, J.M. 1999: Donor age and delayed graft function as predictors of renal allograft survival in rejection-free patients. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 14(4): 930-935
Newman, H.; Reems, J.Anna.; Rigley, T.H.; Bravo, D.; Strong, D.Michael. 2003: Donor age and gender are the strongest predictors of marrow recovery from cadaveric vertebral bodies. Cell Transplantation 12(1): 83-90
Cohen, M.A.; Lindheim, S.R.; Sauer, M.V. 1999: Donor age is paramount to success in oocyte donation. Human Reproduction 14(11): 2755-2758
de La Rubia, J.; Díaz, M.A.; Verdeguer, A.; Pascual, M.J.; Arbona, C.; Arrieta, R.; Brunet, S.; Bargay, J.; Martínez, C.; Espigado, I.; Serrano, D.; Alegre, A.; de Arriba, F.; de La Serna, J.; Zamora, C.; Benlloch, L.; Sanz, M.A. 2001: Donor age-related differences in PBPC mobilization with rHuG-CSF. Transfusion 41(2): 201-205
Räisänen-Sokolowski, A.; Glysing-Jensen, T.; Russell, M.E. 1999: Donor and recipient contributions of ICAM-1 and P-selectin in parenchymal rejection and graft arteriosclerosis: Insights from double knockout mice. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 18(8): 735-743
Bakonyi, A.; Berho, M.; Ruiz, P.; Misiakos, E.P.; Carreno, M.; de Faria, W.; Sommariva, A.; Inverardi, L.; Miller, J.; Ricordi, C.; Tzakis, A.G. 2001: Donor and recipient pretransplant conditioning with nonlethal radiation and antilymphocyte serum improves the graft survival in a rat small bowel transplant model. Transplantation 72(6): 983-988
Hareuveni, M.; Merchav, H.; Austerlitz, N.; Rahimi-Levene, N.; Ben-Tal, O.; Rahimi-Leveen, N. 2002: Donor anti-Jk(a) causing hemolysis in a liver transplant recipient. Transfusion 42(3): 363-367
Van der Hoeven, J.A.; Lindell, S.; van Schilfgaarde, R.; Molema, G.; Ter Horst, G.J.; Southard, J.H.; Ploeg, R.J. 2001: Donor brain death reduces survival after transplantation in rat livers preserved for 20 hr. Transplantation 72(10): 1632-1636
Qazi, Y.A.; Ali, Y.; Venuto, R.C. 2003: Donor calculi induced acute renal failure. Renal Failure 25(2): 315-322
Schnuelle, P.; Lorenz, D.; Mueller, A.; Trede, M.; Van Der Woude, F.J. 1999: Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation. Kidney International 56(2): 738-746
Paglieroni, T.G.; Perez, R.; Katznelson, S.; Muto, K.; Chang, T.; Scott, S.; MacKenzie, M.R.; Holland, P.V. 1999: Donor cell induced CD69 expression and intracellular IL-2 and IL-4 production by peripheral blood lymphocytes isolated from kidney transplant recipients. Human Immunology 60(1): 41-56
Ehl, S.; Barchet, W.; Oehen, S.; Aichele, P.; Hombach, J.; Hengartner, H.; Zinkernagel, R.M. 2000: Donor cell persistence and activation-induced unresponsiveness of peripheral CD8+ T cells. European Journal of Immunology 30(3): 883-891
Barker, J.E.; Schuldt, A.J.T.; Lessard, M.D.; Jude, C.D.; Vogler, C.A.; Soper, B.W. 2003: Donor cell replacement in mice transplanted in utero is limited by immune-independent mechanisms. Blood Cells Molecules and Diseases 31(2): 291-297
Oback, B.ör.; Wells, D. 2002: Donor cells for nuclear cloning: many are called, but few are chosen. Cloning and Stem Cells 4(2): 147-168
Kollman, C.; Howe, C.W.; Anasetti, C.; Antin, J.H.; Davies, S.M.; Filipovich, A.H.; Hegland, J.; Kamani, N.; Kernan, N.A.; King, R.; Ratanatharathorn, V.; Weisdorf, D.; Confer, D.L. 2001: Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: The effect of donor age. Blood 98(7): 2043-2051
Goebel, W.Scott.; Yoder, M.C.; Pech, N.K.; Dinauer, M.C. 2002: Donor chimerism and stem cell function in a murine congenic transplantation model after low-dose radiation conditioning: Effects of a retroviral-mediated gene transfer protocol and implications for gene therapy. Experimental Hematology 30(11): 1324-1332
Weill, D. 2002: Donor criteria in lung transplantation: an issue revisited. Chest 121(6): 2029-2031
Marshall, S.E.; McLaren, A.J.; McKinney, E.F.; Bird, T.G.; Haldar, N.A.; Bunce, M.; Morris, P.J.; Welsh, K.I. 2001: Donor cytokine genotype influences the development of acute rejection after renal transplantation. Transplantation 71(3): 469-476
O'Connell, P.J.; Burlingham, W.J. 1999: Donor dendritic cell persistence in organ allograft recipients in the absence of immunosuppression. Journal of Leukocyte Biology 66(2): 301-305
Nakagawa, K.; Matsuno, T.; Iwagaki, H.; Morimoto, Y.; Fujiwara, T.; Sadamori, H.; Inagaki, M.; Urushihara, N.; Yagi, T.; Tanaka, N. 2001: Donor dendritic cells and recipient Kupffer cells in the induction of donor-specific immune hyporesponsiveness. Journal of International Medical Research 29(2): 119-130
Reinisch, W.; Lichtenberger, C.; Steger, G.; Tillinger, W.; Scheiner, O.; Gangl, A.; Maurer, D.; Willheim, M. 2003: Donor dependent, interferon-gamma induced HLA-DR expression on human neutrophils in vivo. Clinical and Experimental Immunology 133(3): 476-484
Buchta, C.; Bittner, C.; Höcker, P.; Macher, M.; Schmid, R.; Seger, C.; Dettke, M. 2003: Donor exposure to the plasticizer di(2-ethylhexyl)phthalate during plateletpheresis. Transfusion 43(8): 1115-1120
Fitzgerald, M.P.; Mollenhauer, J.; Brubaker, L. 2001: Donor fascia in urogynaecological procedures: A canine model. BJU International 87(7): 682-689
Murata, S.I.; Kuśba, J.; Piszczek, G.; Gryczynski, I.; Lakowicz, J.R. 2000: Donor fluorescence decay analysis for energy transfer in double-helical DNA with various acceptor concentrations. Biopolymers 57(5): 306-315
Hoenicke, E.M.; Peterseim, D.S.; Ducko, C.T.; Sun, X.; Damiano, R.J. 2000: Donor heart preservation with the potassium channel opener pinacidil: Comparison with University of Wisconsin and St. Thomas' solution. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 19(3): 286-297
Sakamoto, T.; Ye, Q.; Lu, L.; Demetris, A.J.; Starzl, T.E.; Murase, N. 1999: Donor hematopoietic progenitor cells in nonmyeloablated rat recipients of allogeneic bone marrow and liver grafts. Transplantation 67(6): 833-840
Bucci, J.R.; Matsumoto, C.S.; Swanson, S.J.; Agodoa, L.Y.C.; Holtzmuller, K.C.; Peters, T.G.; Abbott, K.C. 2002: Donor hepatitis C seropositivity: clinical correlates and effect on early graft and patient survival in adult cadaveric kidney transplantation. Journal of the American Society of Nephrology: Jasn 13(12): 2974-2982
Tan, H.P.; Samaniego, M.D.; Montgomery, R.A.; Burdick, J.F.; Maley, W.R.; Kraus, E.S.; Ratner, L.E. 2001: Donor horseshoe kidneys for transplantation. Transplantation 72(5): 869-873
Carmeli, Y.S.; Birenbaum-Carmeli, D.; Madgar, I.; Weissenberg, R. 2001: Donor insemination in Israel. Recipients' choice of donor. Journal of Reproductive Medicine 46(8): 757-762
Carmeli, Y.S.; Carmeli, D.B.; Matilsky YSM; Kalderon, I.; Yavetz, H. 2001: Donor insemination in Israel: sociodemographic aspects. Journal of Biosocial Science 33(2): 311-314
Cullup, H.; Dickinson, A.M.; Jackson, G.H.; Taylor, P.R.; Cavet, J.; Middleton, P.G. 2001: Donor interleukin 1 receptor antagonist genotype associated with acute graft-versus-host disease in human leucocyte antigen-matched sibling allogeneic transplants. British Journal of Haematology 113(3): 807-813
Bijlsma, F.J.; vanKuik, J.; Tilanus, M.G.J.; deJonge, N.; Rozemuller, E.H.; van den Tweel, J.G.; Gmelig-Meyling, F.H.J.; deWeger, R.A. 2002: Donor interleukin-4 promoter gene polymorphism influences allograft rejection after heart transplantation. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 21(3): 340-346
Teshima, T.; Liu, C.; Lowler, K.P.; Dranoff, G.; Ferrara, J.L.M. 2002: Donor leukocyte infusion from immunized donors increases tumor vaccine efficacy after allogeneic bone marrow transplantation. Cancer Research 62(3): 796-800
Vainikka, T.; Heikkilä, L.; Kukkonen, S.; Toivonen, H.; Verkkala, K.; Mattila, S. 1999: Donor lung pretreatment with prostaglandin E(1) does not improve lung graft preservation. European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes 31(5): 429-436
Kröger, N.; Krüger, W.; Renges, H.; Zabelina, T.; Stute, N.; Jung, R.; Wittkowsky, G.; Kuse, R.; Zander, A. 2001: Donor lymphocyte infusion enhances remission status in patients with persistent disease after allografting for multiple myeloma. British Journal of Haematology 112(2): 421-423
Leda, M.; Ladon, D.; Pieczonka, A.; Boruczkowski, D.; Jólkowska, J.; Witt, M.; Wachowiak, J. 2001: Donor lymphocyte infusion followed by interferon-alpha plus low dose cyclosporine A for modulation of donor CD3 cells activity with monitoring of minimal residual disease and cellular chimerism in a patient with first hematologic relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation. Leukemia Research 25(4): 353-357
De Rosa, G.; Pezzullo, L.; Scarpato, N.; Selleri, C.; Lucania, A.; Rotoli, B. 2000: Donor lymphocyte infusion for post-transplant relapse of Hodgkin's lymphoma. Haematologica 85(7): 780-781
Guglielmi, C.; Arcese, W.; Dazzi, F.; Brand, R.; Bunjes, D.; Verdonck, L.F.; Schattenberg, A.; Kolb, H.-J.; Ljungman, P.; Devergie, A.; Bacigalupo, A.; Gomez, M.; Michallet, M.; Elmaagacli, A.; Gratwohl, A.; Apperley, J.; Niederwieser, D. 2002: Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose. Blood 100(2): 397-405
Baron, F.; Dresse, M.F.; Beguin, Y. 2000: Donor lymphocyte infusion to eradicate recurrent host hematopoiesis after allogeneic BMT for sickle cell disease. Transfusion 40(9): 1071-1073
Mapara, M.Y.; Kim, Y-Mi.; Marx, J.; Sykes, M. 2003: Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus-leukemia effects after conversion to full donor chimerism. Transplantation 76(2): 297-305
Owaidah, T.M. 2003: Donor lymphocyte infusion. An adaptive cellular immunotherapy for treatment of hematological malignancies. Saudi Medical Journal 24(2): 138-141
Dazzi, F.; Szydlo, R.M.; Goldman, J.M. 1999: Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: Where we now stand. Experimental Hematology 27(10): 1477-1486
Lokhorst, H.M.; Schattenberg, A.; Cornelissen, J.J.; van Oers, M.H.; Fibbe, W.; Russell, I.; Donk, N.W.; Verdonck, L.F. 2000: Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 18(16): 3031-3037
Riera, L.; Koziner, B. 2000: Donor lymphocyte infusions for the treatment of relapse after allogeneic hematopoietic stem cell transplantation. Medicina (Buenos Aires) 60(2): 259-269
Mapara, M.Y.; Kim, Y-Mi.; Wang, S-Ping.; Bronson, R.; Sachs, D.H.; Sykes, M. 2002: Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells. Blood 100(5): 1903-1909
Flesland, O.; Pfeffer, P.F.; Solheim, B.G.; Mellbye, O.J. 2003: Donor lymphocytes transferred with the graft to kidney recipients. Potential for establishing microchimerism. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 28(2): 125-128
Delgado, D.H.; Rao, V.; Ross, H.J. 2002: Donor management in cardiac transplantation. Canadian Journal of Cardiology 18(11): 1217-1223
Western, K.H.; Videm, V. 2000: Donor neutrophil function after plateletpheresis. Transfusion 40(11): 1414-1418
Opsahl, M.S.; Thorsell, L.P.; Geltinger, M.E.; Iwaszko, M.A.; Blauer, K.L.; Sherins, R.J. 2002: Donor oocyte cytoplasmic transfer did not enhance implantation of embryos of women with poor ovarian reserve. Journal of Assisted Reproduction and Genetics 19(3): 113-117
Fall, A.J.; Aitchison, J.D.; Krause, A.; Hasan, A.; Hamilton, J.R.; Gould, F.K. 2000: Donor organ transmission of varicella zoster due to cardiac transplantation. Transplantation 70(1): 211-213
Baehner, R.; Magrane, G.; Balassanian, R.; Chang, C.; Millward, C.; Wakil, A.E.; Osorio, R.W.; Waldman, F.M. 2000: Donor origin of neuroendocrine carcinoma in 2 transplant patients determined by molecular cytogenetics. Human Pathology 31(11): 1425-1429
Benson, S.R.C.; Ready, A.R.; Savage, C.O.S. 2002: Donor platelet and leukocyte load identify renal allografts at an increased risk of acute rejection. Transplantation 73(1): 93-100
Felleiter, P.; Freudenberg, J.; Wiesneth, M.; Kubanek, B. 1999: Donor reactions and traffic risks in autologous blood predeposits. Infusionstherapie und Transfusionmedizin 26(5): 267-271
Shimoyama, R.; Nakase, T.; Kojima, S.; Tanaka, S.; Yamamori, K.; Kaneko, C.; Ishimaru, K.; Ikeda, H. 2002: Donor selection in Japan: A trial of new criteria with predonation haemoglobin testing. Vox Sanguinis 82(2): 72-75
Chen, C.D.; Helfman, D.M. 1999: Donor site competition is involved in the regulation of alternative splicing of the rat beta-tropomyosin pre-mRNA. Rna 5(2): 290-301
Silber, J.S.; Anderson, D.Greg.; Daffner, S.D.; Brislin, B.T.; Leland, J.Martin.; Hilibrand, A.S.; Vaccaro, A.R.; Albert, T.J. 2003: Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion. Spine 28(2): 134-139
Tang, C.L.; Mahoney, J.L.; McKee, M.D.; Richards, R.R.; Waddell, J.P.; Louie, B. 1998: Donor site morbidity following vascularized fibular grafting. Microsurgery 18(6): 383-386
Im, S.; Lee, E.So.; Kim, W.; On, W.; Kim, J.; Lee, M.; Kang, W.Hyoung. 2002: Donor specific response of estrogen and progesterone on cultured human melanocytes. Journal of Korean Medical Science 17(1): 58-64
Pulai, J.I.; Zakeri, H.; Kwok, P.Y.; Kim, J.H.; Wu, J.; Schonfeld, G. 1998: Donor splice mutation (665 + 1 G_T) in familial hypobetalipoproteinemia with no detectable apoB truncation. American Journal of Medical Genetics 80(3): 218-220
Welty, F.K.; Guida, K.A.; Andersen, J.J. 2001: Donor splice-site mutation (210+1G_C) in the ApoB gene causes a very low level of ApoB-100 and LDL cholesterol. Arteriosclerosis Thrombosis and Vascular Biology 21(11): 1864-1865
Yamani, M.H.; Starling, R.C.; Cook, D.J.; Tuzcu, E.Murat.; Abdo, A.; Paul, P.; Powell, K.; Ratliff, N.B.; Yu, Y.; McCarthy, P.M.; Young, J.B. 2003: Donor spontaneous intracerebral hemorrhage is associated with systemic activation of matrix metalloproteinase-2 and matrix metalloproteinase-9 and subsequent development of coronary vasculopathy in the heart transplant recipient. Circulation 108(14): 1724-1728
Bubnic, S.J.; Keating, A. 2002: Donor stem cells home to marrow efficiently and contribute to short- and long-term hematopoiesis after low-cell-dose unconditioned bone marrow transplantation. Experimental Hematology 30(6): 606-611
Zavialov, A.V.; Kersley, J.; Korpela, T.; Zav'yalov, V.P.; Macintyre, S.; Knight, S.D. 2002: Donor strand complementation mechanism in the biogenesis of non-pilus systems. Molecular Microbiology 45(4): 983-995
Goan, S.R.; Junghahn, I.; Wissler, M.; Becker, M.; Aumann, J.; Just, U.; Martiny-Baron, G.; Fichtner, I.; Henschler, R. 2000: Donor stromal cells from human blood engraft in NOD/SCID mice. Blood 96(12): 3971-3978
Shao, J.; Zhang, J.; Kowal, P.; Wang, P.George. 2002: Donor substrate regeneration for efficient synthesis of globotetraose and isoglobotetraose. Applied and Environmental Microbiology 68(11): 5634-5640
Seto, N.O.; Compston, C.A.; Evans, S.V.; Bundle, D.R.; Narang, S.A.; Palcic, M.M. 1999: Donor substrate specificity of recombinant human blood group A, B and hybrid A/B glycosyltransferases expressed in Escherichia coli. European Journal of Biochemistry 259(3): 770-775
Gourishankar, S.; Jhangri, G.S.; Cockfield, S.M.; Halloran, P.F. 2003: Donor tissue characteristics influence cadaver kidney transplant function and graft survival but not rejection. Journal of the American Society of Nephrology: Jasn 14(2): 493-499
Valentin, J.F.; Bruijn, J.A.; Paul, L.C. 2000: Donor treatment with mycophenolate mofetil: protection against ischemia-reperfusion injury in the rat. Transplantation 69(3): 344-350
Polyak, M.M.; Arrington, B.O.; Kapur, S.; Stubenbord, W.T.; Kinkhabwala, M. 2000: Donor treatment with phentolamine mesylate improves machine preservation dynamics and early renal allograft function. Transplantation 69(1): 184-186
Phinney, D.G.; Kopen, G.; Righter, W.; Webster, S.; Tremain, N.; Prockop, D.J. 1999: Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. Journal of Cellular Biochemistry 75(3): 424-436
Sabbe, R.; Picchio, G.R.; Pastore, C.; Chaloin, O.; Hartley, O.; Offord, R.; Mosier, D.E. 2001: Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression. Journal of Virology 75(2): 661-671
Karpov, E.A.; Gladun, I.V.; Belozerova, O.L.; Odinokova, N.A. 1999: Donor-acceptor interaction between buckwheat organs at the period of forming of fruit under the influence of growing regulator. Sel'skokhozyaistvennaya Biologiya 1999(5): 57-62
De Soyza, A.G.; Dark, J.H.; Parums, D.V.; Curtis, A.; Corris, P.A. 2001: Donor-acquired small cell lung cancer following pulmonary transplantation. Chest 120(3): 1030-1031
Haltrich, Ién.; Müller, J.; Szabó, J.; Kovács, Gábor.; Kóos, Rália.; Poros, A.; Dobos, M.; Fekete, Görgy. 2003: Donor-cell myelodysplastic syndrome developing 13 years after marrow grafting for aplastic anemia. Cancer Genetics and Cytogenetics 142(2): 124-128
Hancock, W.W.; Gao, W.; Csizmadia, V.; Faia, K.L.; Shemmeri, N.; Luster, A.D. 2001: Donor-derived IP-10 initiates development of acute allograft rejection. Journal of Experimental Medicine 193(8): 975-980
Seltsam, A.; Hell, A.; Heymann, G.; Salama, A. 2001: Donor-derived alloantibodies and passenger lymphocyte syndrome in two of four patients who received different organs from the same donor. Transfusion 41(3): 365-370
Crough, T.; Nieda, M.; Morton, J.; Bashford, J.; Durrant, S.; Nicol, A.J. 2002: Donor-derived b2a2-specific T cells for immunotherapy of patients with chronic myeloid leukemia. Journal of ImmunoTherapy 25(6): 469-475
Popa, E.R.; Kas-Deelen, A.M.; Hepkema, B.G.; Van Son, W.J.; The, T.Hauw.; Harmsen, M.C. 2002: Donor-derived circulating endothelial cells after kidney transplantation. Transplantation 74(9): 1320-1327
Rifle, Gérard.; Mousson, C. 2003: Donor-derived hematopoietic cells in organ transplantation: a major step toward allograft tolerance?. Transplantation 75(9): 3s-7s
Hervé, P. 2003: Donor-derived hematopoietic stem cells in organ transplantation: technical aspects and hurdles yet to be cleared. Transplantation 75(9 Suppl): 55s-57s
Yang, Y.G.; Dey, B.R.; Sergio, J.J.; Pearson, D.A.; Sykes, M. 1998: Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12. Journal of Clinical Investigation 102(12): 2126-2135
Yang, Y.-G.; Qi, J.; Wang, M.-G.; Sykes, M. 2002: Donor-derived interferon gamma separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells. Blood 99(11): 4207-4215
Bodvarsson, S.; Burlingham, W.; Kusaka, S.; Hafez, G.R.; Becker, B.N.; Pintar, T.; Sollinger, H.W.; Albertini, M.R. 2001: Donor-derived small cell lung carcinoma in a kidney transplant recipient. Cancer 92(9): 2429-2434
Lu, H-Fu.; Shekarriz, B.; Stoller, M.L. 2002: Donor-gifted allograft urolithiasis: Early percutaneous management. Urology 59(1): 25-27
Young, K.J.; Yang, L.; Phillips, M.J.; Zhang, L. 2002: Donor-lymphocyte infusion induces transplantation tolerance by activating systemic and graft-infiltrating double-negative regulatory T cells. Blood 100(9): 3408-3414
Balduini, C.L.; Frassoni, F.; Noris, P.; Klersy, C.; Iannone, A.M.; Bacigalupo, A.; Giorgiani, G.; Di Pumpo, M.; Locatelli, F. 2001: Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor. British Journal of Haematology 114(4): 951-953
Clave, E.; Molldrem, J.; Hensel, N.; Raptis, A.; Barrett, A.J. 1999: Donor-recipient polymorphism of the proteinase 3 gene: a potential target for T-cell alloresponses to myeloid leukemia. Journal of ImmunoTherapy 22(1): 1-6
Cotler, S.J.; Gaur, L.K.; Gretch, D.R.; Wile, M.; Strong, D.M.; Bronner, M.P.; Carithers, R.L.; Emond, M.J.; Perkins, J.D.; Nelson, K.A. 1998: Donor-recipient sharing of HLA class II alleles predicts earlier recurrence and accelerated progression of hepatitis C following liver transplantation. Tissue Antigens 52(5): 435-443
Kartus, J.; Movin, T.; Karlsson, J. 2001: Donor-site morbidity and anterior knee problems after anterior cruciate ligament reconstruction using autografts. Arthroscopy: the Journal of Arthroscopic and Related Surgery: Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association 17(9): 971-980
van Besouw, N.M.; van der Mast, B.J.; de Kuiper, P.; Smak Gregoor, P.J.; Vaessen, L.M.; IJzermans, J.N.; van Gelder, T.; Weimar, W. 2000: Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced. Transplantation 70(1): 136-143
Margenthaler, J.A.; Kataoka, M.; Flye, M.W. 2003: Donor-specific antigen transfusion-mediated skin-graft tolerance results from the peripheral deletion of donor-reactive CD8+ T cells. Transplantation 75(12): 2119-2127
Inuzuka, S.; Koga, S.; Nishikido, M.; Miyata, Y.; Kanda, S.; Shimokawa, I.; Tanaka, M.; Saito, Y.; Kanetake, H. 2002: Donor-specific blood transfusion prolongs cardiac allograft survival in rats by low nitric oxide production and elevated serum levels of prostaglandin E(2). Immunology Letters 83(2): 119-124
Landolina, M.; De Ferrari, G.M.; Cantù, F.; Campana, C. 2000: Donor-to-recipient decremental conduction of atrial fibrillation following orthotopic heart transplantation: Insights into the mechanism of atrioatrial conduction. Journal of Cardiovascular Electrophysiology 11(9): 1043-1047
Burket, J.S.; Chenoweth, C.E.; Meyer, T.L.; Barg, N.L. 1999: Donor-to-recipient transmission of bacteria as an unusual cause of mediastinitis in a heart transplant recipient. Infection Control and Hospital Epidemiology 20(2): 132-133
Grauhan, O.; Patzurek, J.; Hummel, M.; Lehmkuhl, H.; Dandel, M.; Pasic, M.; Weng, Y.; Hetzer, R. 2003: Donor-transmitted coronary atherosclerosis. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 22(5): 568-573
Hoffmann, P.; Ermann, J.; Edinger, M.; Fathman, C.Garrison.; Strober, S. 2002: Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. Journal of Experimental Medicine 196(3): 389-399
Zhao, Y.; Lan, F.; Gan, J.; Yao, X.; Reisner, Y. 1999: Donor-type chimerism determination by competitive polymerase chain reaction (PCR) in a primate model for bone marrow transplantation. Transplantation 68(10): 1573-1577
Hurley, D.J.; Tor, Y. 2002: Donor/acceptor interactions in systematically modified Ru(II)-Os(II) oligonucleotides. Journal of the American Chemical Society 124(44): 13231-13241
Karu, T.I.; Pyatibrat, L.V.; Kalendo, G.S. 2001: Donors of NO and pulsed radiation at lambda = 820 nm exert effects on cell attachment to extracellular matrices. Toxicology Letters 121(1): 57-61
Wilson, D.J.; Fisher, A.; Das, K.; Goerlitz, F.; Holland, B.K.; De La Torre, A.N.; Merchant, A.; Seguel, J.; Samanta, A.K.; Koneru, B. 2003: Donors with cardiac arrest: improved organ recovery but no preconditioning benefit in liver allografts. Transplantation 75(10): 1683-1687
Buell, J.F.; Trofe, J.; Sethuraman, G.; Hanaway, M.J.; Beebe, T.M.; Gross, T.G.; Alloway, R.; First, M.Roy.; Woodle, E.Steve. 2003: Donors with central nervous system malignancies: are they truly safe?. Transplantation 76(2): 340-343
O'Farrell, N. 2001: Donovanosis: An update. International Journal of STD and AIDS 12(7): 423-427
Denes, G.; Signorini, M. 2001: Door but not four and 4 a category specific transcoding deficit in a pure acalculic patient. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior 37(2): 267-277
Rocca, W.A.; Savettieri, G.; Anderson, D.W.; Meneghini, F.; Grigoletto, F.; Morgante, L.; Reggio, A.; Salemi, G.; Patti, F.; Di Perri, R. 2001: Door-to-door prevalence survey of epilepsy in three Sicilian municipalities. Neuroepidemiology 20(4): 237-241
Bertoldi, M.; Voltattorni, C.B. 2001: Dopa decarboxylase exhibits low pH half-transaminase and high pH oxidative deaminase activities toward serotonin (5-hydroxytryptamine). Protein Science: a Publication of the Protein Society 10(6): 1178-1186
Hershey, T.; Black, K.J.; Carl, J.L.; Perlmutter, J.S. 2000: Dopa-induced blood flow responses in nonhuman primates. Experimental Neurology 166(2): 342-349
Romstad, A.; Dupont, E.; Krag-Olsen, B.; Østergaard, K.; Guldberg, P.; Güttler, F. 2003: Dopa-responsive dystonia and Tourette syndrome in a large Danish family. Archives of Neurology 60(4): 618-622
Furukawa, Y.; Guttman, M.; Sparagana, S.P.; Trugman, J.M.; Hyland, K.; Wyatt, P.; Lang, A.E.; Rouleau, G.A.; Shimadzu, M.; Kish, S.J. 2000: Dopa-responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene. Annals of Neurology 47(4): 517-520
Hwu, W.L.; Chiou, Y.W.; Lai, S.Y.; Lee, Y.M. 2000: Dopa-responsive dystonia is induced by a dominant-negative mechanism. Annals of Neurology 48(4): 609-613
Furukawa, Y.; Graf, W.D.; Wong, H.; Shimadzu, M.; Kish, S.J. 2001: Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations. Neurology 56(2): 260-263
Ebersbach, G.; Stoeck, M.; Mueller, J.; Wissel, J.; Poewe, W. 2000: Dopa-responsive postural tremor in Parkinson's disease. Aktuelle Neurologie 27(7): 327-331
Ama, P.F.M.; Ama, V.J.; Kamga, J.P.; Sato, G.; Laure, P. 2002: Dopage et sport: Connaissances et attitudes des pharmaciens de la ville de Yaounde. Science and Sports 17(3): 135-139
Yamamoto, K.; Cubells, J.F.; Gelernter, J.; Benkelfat, C.; Lalonde, P.; Bloom, D.; Lal, S.; Labelle, A.; Turecki, G.; Rouleau, G.A.; Joober, R. 2003: Dopamine beta-hydroxylase (DBH) gene and schizophrenia phenotypic variability: a genetic association study. American Journal of Medical Genetics. Part B Neuropsychiatric Genetics: the Official Publication of the International Society of Psychiatric Genetics 117b(1): 33-38
Soyka, M.; Preuss, U.W.; Koller, G.; Zill, P.; Bondy, B. 2002: Dopamine D 4 receptor gene polymorphism and extraversion revisited: Results from the Munich gene bank project for alcoholism. Journal of Psychiatric Research 36(6): 429-435
Hanson, G.R.; Keefe, K.A. 1999: Dopamine D-1 regulation of caudate neurotensin mRNA in the presence or absence of the nigrostriatal dopamine pathway. Brain Research. Molecular Brain Research 66(1-2): 111-121
Kerr, J.N.; Wickens, J.R. 2001: Dopamine D-1/D-5 receptor activation is required for long-term potentiation in the rat neostriatum in vitro. Journal of Neurophysiology 85(1): 117-124
Hersi, A.I.; Kitaichi, K.; Srivastava, L.K.; Gaudreau, P.; Quirion, R. 2000: Dopamine D-5 receptor modulates hippocampal acetylcholine release. Brain Research. Molecular Brain Research 76(2): 336-340
Black, K.J.; Hershey, T.; Gado, M.H.; Perlmutter, J.S. 2000: Dopamine D(1) agonist activates temporal lobe structures in primates. Journal of Neurophysiology 84(1): 549-557
Sugahara, M.; Shiraishi, H. 1999: Dopamine D1 and D2 receptor agents and their interaction influence the synaptic density of the rat prefrontal cortex. Neuroscience Letters 259(3): 141-144
Bahk, J.Y.; Li, S.; Park, M.S.; Kim, M.O. 2002: Dopamine D1 and D2 receptor mRNA up-regulation in the caudate-putamen and nucleus accumbens of rat brains by smoking. Progress in Neuro-Psychopharmacology and Biological Psychiatry 26(6): 1095-1104
Weed, M.R.; Woolverton, W.L.; Paul, I.A. 1998: Dopamine D1 and D2 receptor selectivities of phenyl-benzazepines in rhesus monkey striata. European Journal of Pharmacology 361(1): 129-142
Ongali, B.; Ase, A.R.; Hébert, C.; Amdiss, F.; Reader, T.A. 2000: Dopamine D(1) and D(2) receptors in the forebrain of dystonia musculorum mutant mice: an autoradiographic survey in relation to dopamine contents. Synapse 37(1): 1-15
Kimmel, H.L.; Joyce, A.R.; Carroll, F.I.; Kuhar, M.J. 2001: Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat. Journal of Pharmacology and Experimental Therapeutics 298(1): 129-140
Floresco, S.B.; Blaha, C.D.; Yang, C.R.; Phillips, A.G. 2001: Dopamine D1 and NMDA receptors mediate potentiation of basolateral amygdala-evoked firing of nucleus accumbens neurons. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 21(16): 6370-6376
Hauber, W.; Lutz, S. 1999: Dopamine D1 or D2 receptor blockade in the globus pallidus produces akinesia in the rat. Behavioural Brain Research 106(1-2): 143-150
Sorg, B.A.; Li, N.; Wu, W.R. 2001: Dopamine D1 receptor activation in the medial prefrontal cortex prevents the expression of cocaine sensitization. Journal of Pharmacology and Experimental Therapeutics 297(2): 501-508
D'aquila, P.S.; Panin, F.; Cossu, M.; Peana, A.T.; Serra, G. 2003: Dopamine D1 receptor agonists induce penile erections in rats. European Journal of Pharmacology 460(1): 71-74
Yao, L.P.; Li, X.X.; Yu, P.Y.; Xu, J.; Asico, L.D.; Jose, P.A. 1998: Dopamine D1 receptor and protein kinase C isoforms in spontaneously hypertensive rats. Hypertension 32(6): 1049-1053
Boksa, P.; Zhang, Y.; Bestawros, A. 2002: Dopamine D1 receptor changes due to caesarean section birth: effects of anesthesia, developmental time course, and functional consequences. Experimental Neurology 175(2): 388-397
Hurley, M.J.; Mash, D.C.; Jenner, P. 2001: Dopamine D(1) receptor expression in human basal ganglia and changes in Parkinson's disease. Brain Research. Molecular Brain Research 87(2): 271-279
Kojima, H.; Ohmori, O.; Shinkai, T.; Terao, T.; Suzuki, T.; Abe, K. 1999: Dopamine D1 receptor gene polymorphism and schizophrenia in Japan. American Journal of Medical Genetics 88(2): 116-119
Sato, M.; Soma, M.; Nakayama, T.; Kanmatsuse, K. 2000: Dopamine D1 receptor gene polymorphism is associated with essential hypertension. Hypertension 36(2): 183-186
Grondin, R.; Goulet, M.; Morissette, M.; Bédard, P.J.; Di Paolo, T. 1999: Dopamine D1 receptor mRNA and receptor levels in the striatum of MPTP monkeys chronically treated with SKF-82958. European Journal of Pharmacology 378(3): 259-263
Rodríguez-Puertas, R.; Herrera-Marschitz, M.; Koistinaho, J.; Hökfelt, T. 1999: Dopamine D1 receptor modulation of glutamate receptor messenger RNA levels in the neocortex and neostriatum of unilaterally 6-hydroxydopamine-lesioned rats. Neuroscience 89(3): 781-797
Grider, J.S.; Ott, C.E.; Jackson, B.A. 2003: Dopamine D1 receptor-dependent inhibition of NaCl transport in the rat thick ascending limb: Mechanism of action. European Journal of Pharmacology 473(2-3): 185-190
Dunah, A.W.; Standaert, D.G. 2001: Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 21(15): 5546-5558
Svenningsson, P.; Fienberg, A.A.; Allen, P.B.; Moine, C.L.; Lindskog, M.; Fisone, G.; Greengard, P.; Fredholm, B.B. 2000: Dopamine D(1) receptor-induced gene transcription is modulated by DARPP-32. Journal of Neurochemistry 75(1): 248-257
Acquas, E.; Di Chiara, G. 1999: Dopamine D(1) receptor-mediated control of striatal acetylcholine release by endogenous dopamine. European Journal of Pharmacology 383(2): 121-127
Schwienbacher, I.; Fendt, M.; Hauber, W.; Koch, M. 2002: Dopamine D1 receptors and adenosine A1 receptors in the rat nucleus accumbens regulate motor activity but not prepulse inhibition. European Journal of Pharmacology 444(3): 161-169
Mo, J.Ling.; Devos, P.; Trausch, Gérard. 2002: Dopamine D1 receptors in the gills of Chinese crab Eriocheir sinensis. Comparative Biochemistry and Physiology. Toxicology and Pharmacology: Cbp 131(4): 433-438
Khroyan, T.V.; Barrett-Larimore, R.L.; Rowlett, J.K.; Spealman, R.D. 2000: Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists. Journal of Pharmacology and Experimental Therapeutics 294(2): 680-687
Dong, Y.; White, F.J. 2003: Dopamine D1-class receptors selectively modulate a slowly inactivating potassium current in rat medial prefrontal cortex pyramidal neurons. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 23(7): 2686-2695
Ricci, A.; Bronzetti, E.; Mignini, F.; Tayebati, S.K.; Zaccheo, D.; Amenta, F. 1999: Dopamine D1-like receptor subtypes in human peripheral blood lymphocytes. Journal of Neuroimmunology 96(2): 234-240
Amenta, F.; Barili, P.; Bronzetti, E.; Ricci, A. 1999: Dopamine D1-like receptor subtypes in the rat kidney: a microanatomical study. Clinical and Experimental Hypertension 21(1-2): 17-23
Mora-Ferrer, C.; Yazulla, S.; Studholme, K.M.; Haak-Frendscho, M. 1999: Dopamine D1-receptor immunolocalization in goldfish retina. Journal of Comparative Neurology 411(4): 705-714
Tong, J.; Ross, B.M.; Sherwin, A.L.; Kish, S.J. 2001: Dopamine D1-stimulated adenylyl cyclase activity in cerebral cortex of autopsied human brain. Neurochemistry International 39(2): 117-125
Svenningsson, P.; Le Moine, C. 2002: Dopamine D1/5 receptor stimulation induces c-fos expression in the subthalamic nucleus: Possible involvement of local D5 receptors. European Journal of Neuroscience 15(1): 133-142
Gong, W.; Neill, D.B.; Lynn, M.; Justice, J.B. 1999: Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site. Neuroscience 93(4): 1349-1358
Gorelova, N.A.; Yang, C.R. 2000: Dopamine D1/D5 receptor activation modulates a persistent sodium current in rat prefrontal cortical neurons in vitro. Journal of Neurophysiology 84(1): 75-87
Van Kampen, J.M.; Stoessl, A.J. 2000: Dopamine D(1A) receptor function in a rodent model of tardive dyskinesia. Neuroscience 101(3): 629-635
Sugamori, K.S.; Scheideler, M.A.; Vernier, P.; Niznik, H.B. 1998: Dopamine D1B receptor chimeras reveal modulation of partial agonist activity by carboxyl-terminal tail sequences. Journal of Neurochemistry 71(6): 2593-2599
Wiesbeck, G.A.; Weijers, H.-G.; Wodarz, N.; Herrmann, M.J.; Johann, M.; Keller, H.K.; Michel, T.M.; Böning, J. 2003: Dopamine D2 (DAD2) and dopamine D3 (DAD3) receptor gene polymorphisms and treatment outcome in alcohol dependence. Journal of Neural Transmission 110(7): 813-820
Wang, Y.; Xu, R.; Sasaoka, T.; Tonegawa, S.; Kung, M.P.; Sankoorikal, E.B. 2000: Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 20(22): 8305-8314
Narkar, V.A.; Hussain, T.; Pedemonte, C.; Lokhandwala, M.F. 2001: Dopamine D(2) receptor activation causes mitogenesis via p44/42 mitogen-activated protein kinase in opossum kidney cells. Journal of the American Society of Nephrology: Jasn 12(9): 1844-1852
Tsai, S-Jen.; Yu, Y.W-Y.; Lin, C-Hua.; Chen, T-Jui.; Chen, S-Ping.; Hong, C-Jee. 2002: Dopamine D2 receptor and N-methyl-D-aspartate receptor 2B subunit genetic variants and intelligence. Neuropsychobiology 45(3): 128-130
Carta, G.; Gessa, G.L.; Nava, F. 1999: Dopamine D(2) receptor antagonists prevent delta(9)-tetrahydrocannabinol-induced antinociception in rats. European Journal of Pharmacology 384(2-3): 153-156
Parsey, R.V.; Oquendo, M.A.; Zea-Ponce, Y.; Rodenhiser, J.; Kegeles, L.S.; Pratap, M.; Cooper, T.B.; Van Heertum, R.; Mann, J.J.; Laruelle, M. 2001: Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression. Biological Psychiatry 50(5): 313-322
Hagelberg, N.; Martikainen, I.K.; Mansikka, H.; Hinkka, S.; Någren, K.; Hietala, J.; Scheinin, H.; Pertovaara, A. 2002: Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity. Pain 99(1-2): 273-279
Hitzemann, R.; Hitzemann, B.; Rivera, S.; Gatley, J.; Thanos, P.; Shou, L.Lu.Siming.; Williams, R.W. 2003: Dopamine D2 receptor binding, Drd2 expression and the number of dopamine neurons in the BXD recombinant inbred series: Genetic relationships to alcohol and other drug associated phenotypes. Alcoholism Clinical and Experimental Research 27(1): 1-11
Kapur, S.; Barsoum, S.C.; Seeman, P. 2000: Dopamine D(2) receptor blockade by haloperidol. (3)H-raclopride reveals much higher occupancy than EEDQ. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 23(5): 595-598
Bressan, R.A.; Jones, H.M.; Ell, P.J.; Pilowsky, L.S. 2001: Dopamine D(2) receptor blockade in schizophrenia. American Journal of Psychiatry 158(6): 971-972
Horvitz, J.C.; Eyny, Y.S. 2000: Dopamine D2 receptor blockade reduces response likelihood but does not affect latency to emit a learned sensory-motor response: implications for Parkinson's disease. Behavioral Neuroscience 114(5): 934-939
Armstrong, D.; Strange, P.G. 2001: Dopamine D2 receptor dimer formation: evidence from ligand binding. Journal of Biological Chemistry 276(25): 22621-22629
Lu, R.B.; Lee, J.F.; Ko, H.C.; Lin, W.W. 2001: Dopamine D2 receptor gene (DRD2) is associated with alcoholism with conduct disorder. Alcoholism Clinical and Experimental Research 25(2): 177-184
Jönsson, E.G.; Sillén, A.; Vares, M.; Ekholm, B.; Terenius, L.; Sedvall, Göran.C. 2003: Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta-analysis. American Journal of Medical Genetics. Part B Neuropsychiatric Genetics: the Official Publication of the International Society of Psychiatric Genetics 119b(1): 28-34
Stefaneanu, L.; Kovacs, K.; Horvath, E.; Buchfelder, M.; Fahlbusch, R.; Lancranjan, L. 2001: Dopamine D2 receptor gene expression in human adenohypophysial adenomas. Endocrine 14(3): 329-336
Serretti, A.; Smeraldi, E. 1999: Dopamine D2 receptor gene not associated with symptomatology of mood disorders. American Journal of Medical Genetics 88(4): 294-297
Oliveri, R.L.; Annesi, G.; Zappia, M.; Civitelli, D.; Montesanti, R.; Branca, D.; Nicoletti, G.; Spadafora, P.; Pasqua, A.A.; Cittadella, R.; Andreoli, V.; Gambardella, A.; Aguglia, U.; Quattrone, A. 1999: Dopamine D2 receptor gene polymorphism and the risk of levodopa-induced dyskinesias in PD. Neurology 53(7): 1425-1430
Müller-Vahl, K.R.; Berding, G.; Kolbe, H.; Meyer, G.J.; Hundeshagen, H.; Dengler, R.; Knapp, W.H.; Emrich, H.M. 2000: Dopamine D2 receptor imaging in Gilles de la Tourette syndrome. Acta Neurologica Scandinavica 101(3): 165-171
Yao, L.; Asai, K.; Jiang, Z.; Ishii, A.; Fan, P.; Gordon, A.S.; Diamond, I. 2001: Dopamine D2 receptor inhibition of adenylyl cyclase is abolished by acute ethanol but restored after chronic ethanol exposure (tolerance). Journal of Pharmacology and Experimental Therapeutics 298(2): 833-839
Wolfe, S.E.; Morris, S.J. 1999: Dopamine D2 receptor isoforms expressed in AtT20 cells differentially couple to G proteins to acutely inhibit high voltage-activated calcium channels. Journal of Neurochemistry 73(6): 2375-2382
Boulay, D.; Depoortere, R.; Perrault, G.; Borrelli, E.; Sanger, D.J. 1999: Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists. Neuropharmacology 38(9): 1389-1396
Cooper, A.J.; Stanford, I.M. 2001: Dopamine D2 receptor mediated presynaptic inhibition of striatopallidal GABA(A) IPSCs in vitro. Neuropharmacology 41(1): 62-71
Wadenberg, M.L.; Soliman, A.; VanderSpek, S.C.; Kapur, S. 2001: Dopamine D(2) receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 25(5): 633-641
Wadenberg, M.L.; Kapur, S.; Soliman, A.; Jones, C.; Vaccarino, F. 2000: Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats. Psychopharmacology 150(4): 422-429
Tallerico, T.; Ulpian, C.; Liu, I.S. 1999: Dopamine D2 receptor promoter polymorphism: No association with schizophrenia. Psychiatry Research 85(2): 215-219
Pinborg, L., H.; Videbaek, C.; Knudsen, G., M.; Swahn, C.-Gunnar; Halldin, C.; Friberg, L.; Paulson, O., B.; Lassen, N., A. 2000: Dopamine D2 receptor quantification in extrastriatal brain regions using (123I)epidepride with bolus/infusion. Synapse (New York) 36(4): 322-329
Salmi, P.; Sproat, B.S.; Ludwig, J.; Hale, R.; Avery, N.; Kela, J.; Wahlestedt, C. 2000: Dopamine D(2) receptor ribozyme inhibits quinpirole-induced stereotypy in rats. European Journal of Pharmacology 388(1): R1-R2
Bozzi, Y.; Borrelli, E. 2002: Dopamine D2 receptor signaling controls neuronal cell death induced by muscarinic and glutamatergic drugs. Molecular and Cellular Neurosciences 19(2): 263-271
Dickinson, S.D.; Sabeti, J.; Larson, G.A.; Giardina, K.; Rubinstein, M.; Kelly, M.A.; Grandy, D.K.; Low, M.J.; Gerhardt, G.A.; Zahniser, N.R. 1999: Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. Journal of Neurochemistry 72(1): 148-156
Hellstrand, M.; Eriksson, E.; Nilsson, C.L. 2002: Dopamine D(2) receptor-induced COX-2-mediated production of prostaglandin E(2) in D(2)-transfected Chinese hamster ovary cells without simultaneous administration of a Ca(2+)-mobilizing agent. Biochemical Pharmacology 63(12): 2151-2158
Watts, V.J.; Taussig, R.; Neve, R.L.; Neve, K.A. 2001: Dopamine D2 receptor-induced heterologous sensitization of adenylyl cyclase requires Galphas: characterization of Galphas-insensitive mutants of adenylyl cyclase V. Molecular Pharmacology 60(6): 1168-1172
Newman-Tancredi, A.; Cussac, D.; Brocco, M.; Rivet, J.M.; Chaput, C.; Touzard, M.; Pasteau, V.; Millan, M.J. 2001: Dopamine D2 receptor-mediated G-protein activation in rat striatum: Functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra. Brain Research 920(1-2): 41-54
Iida, M.; Miyazaki, I.; Tanaka, K.; Kabuto, H.; Iwata-Ichikawa, E.; Ogawa, N. 1999: Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist. Brain Research 838(1-2): 51-59
Centonze, D.; Usiello, A.; Gubellini, P.; Pisani, A.; Borrelli, E.; Bernardi, G.; Calabresi, P. 2002: Dopamine D2 receptor-mediated inhibition of dopaminergic neurons in mice lacking D2L receptors. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 27(5): 723-726
Ennis, M.; Zhou, F.M.; Ciombor, K.J.; Aroniadou-Anderjaska, V.; Hayar, A.; Borrelli, E.; Zimmer, L.A.; Margolis, F.; Shipley, M.T. 2001: Dopamine D2 receptor-mediated presynaptic inhibition of olfactory nerve terminals. Journal of Neurophysiology 86(6): 2986-2997
Wang, Z.; Yu, G.; Cascio, C.; Liu, Y.; Gingrich, B.; Insel, T.R. 1999: Dopamine D2 receptor-mediated regulation of partner preferences in female prairie voles (Microtus ochrogaster): a mechanism for pair bonding?. Behavioral Neuroscience 113(3): 602-611
Sederholm, F.; Johnson, A.E.; Brodin, U.; Södersten, P. 2002: Dopamine D(2) receptors and ingestive behavior: brainstem mediates inhibition of intraoral intake and accumbens mediates aversive taste behavior in male rats. Psychopharmacology 160(2): 161-169
Kapur, S.; Remington, G. 2001: Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient. Biological Psychiatry 50(11): 873-883
Tupala, E.; Hall, H.åk.; Bergström, K.; Mantere, T.; Räsänen, P.; Särkioja, T.; Tiihonen, J. 2003: Dopamine D2 receptors and transporters in type 1 and 2 alcoholics measured with human whole hemisphere autoradiography. Human Brain Mapping 20(2): 91-102
Wang, H.; Pickel, V.M. 2002: Dopamine D2 receptors are present in prefrontal cortical afferents and their targets in patches of the rat caudate-putamen nucleus. Journal of Comparative Neurology 442(4): 392-404
Suhara, T.; Yasuno, F.; Sudo, Y.; Yamamoto, M.; Inoue, M.; Okubo, Y.; Suzuki, K. 2001: Dopamine D2 receptors in the insular cortex and the personality trait of novelty seeking. Neuroimage 13(5): 891-895
Gingrich, B.; Liu, Y.; Cascio, C.; Wang, Z.; Insel, T.R. 2000: Dopamine D2 receptors in the nucleus accumbens are important for social attachment in female prairie voles (Microtus ochrogaster). Behavioral Neuroscience 114(1): 173-183
Ko, F.; Seeman, P.; Sun, W.S.; Kapur, S. 2002: Dopamine D2 receptors internalize in their low-affinity state. Neuroreport 13(8): 1017-1020
Lindgren, N.; Xu, Z.Q.; Herrera-Marschitz, M.; Haycock, J.; Hökfelt, T.; Fisone, G. 2001: Dopamine D(2) receptors regulate tyrosine hydroxylase activity and phosphorylation at Ser40 in rat striatum. European Journal of Neuroscience 13(4): 773-780
Levens, N.; Green, T.A.; Akins, C.K.; Bardo, M.T. 2000: Dopamine D(2)-like receptor binding in the brain of male Japanese quail (Coturnix japonica). Neuroscience Letters 296(2-3): 77-80
Luippold, G.; Schneider, S.; Stefanescu, A.; Benöhr, P.; Mühlbauer, B. 2001: Dopamine D2-like receptors and amino acid-induced glomerular hyperfiltration in humans. British Journal of Clinical Pharmacology 51(5): 415-421
Amenta, F.; Bronzetti, E.; Felici, L.; Ricci, A.; Tayebati, S.K. 1999: Dopamine D2-like receptors on human peripheral blood lymphocytes: A radioligand binding assay and immunocytochemical study. Journal of Autonomic Pharmacology 19(3): 151-159
Momiyama, T.; Koga, E. 2001: Dopamine D(2)-like receptors selectively block N-type Ca(2+) channels to reduce GABA release onto rat striatal cholinergic interneurones. Journal of Physiology 533(Pt 2): 479-492
Wolfe, S.E.; Howard, D.E.; Schetz, J.A.; Cheng, C.J.; Webber, R.; Beatty, D.M.; Chronwall, B.M.; Morris, S.J. 1999: Dopamine D2-receptor isoforms expressed in AtT20 cells inhibit Q-type high-voltage-activated Ca2+ channels via a membrane-delimited pathway. Journal of Neurochemistry 72(2): 479-490
Sinnott, R.S.; Mach, R.H.; Nader, M.A. 1999: Dopamine D2/D3 receptors modulate cocaine's reinforcing and discriminative stimulus effects in rhesus monkeys. Drug and Alcohol Dependence 54(2): 97-110
Smith, J.W.; Fetsko, L.A.; Xu, R.; Wang, Y. 2002: Dopamine D2L receptor knockout mice display deficits in positive and negative reinforcing properties of morphine and in avoidance learning. Neuroscience 113(4): 755-765
Vukhac, K.L.; Sankoorikal, E.B.; Wang, Y. 2001: Dopamine D2L receptor- and age-related reduction in offensive aggression. Neuroreport 12(5): 1035-1038
Le Foll, B.; Schwartz, J.C.; Sokoloff, P. 2000: Dopamine D3 receptor agents as potential new medications for drug addiction. European Psychiatry: the Journal of the Association of European Psychiatrists 15(2): 140-146
Boulay, D.; Depoortere, R.; Rostene, W.; Perrault, G.; Sanger, D.J. 1999: Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor activity in D3 knock-out and wild-type mice. Neuropharmacology 38(4): 555-565
Vorel, S.R.; Ashby, C.R.; Paul, M.; Liu, X.; Hayes, R.; Hagan, J.J.; Middlemiss, D.N.; Stemp, G.; Gardner, E.L. 2002: Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 22(21): 9595-9603
Boyce, J.M.; Risinger, F.O. 2002: Dopamine D3 receptor antagonist effects on the motivational effects of ethanol. Alcohol 28(1): 47-55
Tremblay, M.; Rouillard, C.; Lévesque, D. 1999: Dopamine D3 receptor antisense administration reduces basal c-fos and NGFI-B mRNA levels in the rat forebrain. Synapse 32(1): 51-57
Kaichi, Y.; Nonaka, R.; Hagino, Y.; Watanabe, M. 2000: Dopamine D3 receptor binding by D3 agonist 7-OH-DPAT (7-hydroxy-dipropylaminotetralin) and antipsychotic drugs measured ex vivo by quantitative autoradiography. Canadian Journal of Physiology and Pharmacology 78(1): 7-11
Jönsson, E.G.; Flyckt, L.; Burgert, E.; Crocq, M-Antoine.; Forslund, K.; Mattila-Evenden, M.; Rylander, G.; Asberg, M.; Nimgaonkar, V.L.; Edman, G.; Bjerkenstedt, L.; Wiesel, F-Axel.; Sedvall, Göran.C. 2003: Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis. Psychiatric Genetics 13(1): 1-12
Garcia-Barceló, M.M.; Lam, L.C.; Ungvari, G.S.; Lam, V.K.; Tang, W.K. 2001: Dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients. Journal of Neural Transmission 108(6): 671-677
Serretti, A.; Lattuada, E.; Cusin, C.; Lilli, R.; Lorenzi, C.; Smeraldi, E. 1999: Dopamine D3 receptor gene not associated with symptomatology of major psychoses. American Journal of Medical Genetics 88(5): 476-480
Thome, J.; Weijers, H.G.; Wiesbeck, G.A.; Sian, J.; Nara, K.; Böning, J.; Riederer, P. 1999: Dopamine D3 receptor gene polymorphism and alcohol dependence: relation to personality rating. Psychiatric Genetics 9(1): 17-21
Retz, W.; Rösler, M.; Supprian, T.; Retz-Junginger, P.; Thome, J. 2003: Dopamine D3 receptor gene polymorphism and violent behavior: relation to impulsiveness and ADHD-related psychopathology. Journal of Neural Transmission 110(5): 561-572
Gurevich, E.V.; Joyce, J.N. 2000: Dopamine D(3) receptor is selectively and transiently expressed in the developing whisker barrel cortex of the rat. Journal of Comparative Neurology 420(1): 35-51
Boyce-Rustay, J.M.; Risinger, F.O. 2003: Dopamine D3 receptor knockout mice and the motivational effects of ethanol. Pharmacology Biochemistry and Behavior 75(2): 373-379
Gyertyán, Ián.; Gál, K. 2003: Dopamine D3 receptor ligands show place conditioning effect but do not influence cocaine-induced place preference. Neuroreport 14(1): 93-98
Xu, M.; Koeltzow, T.E.; Cooper, D.C.; Tonegawa, S.; White, F.J. 1999: Dopamine D3 receptor mutant and wild-type mice exhibit identical responses to putative D3 receptor-selective agonists and antagonists. Synapse 31(3): 210-215
Kahsar-Miller, M.; Boots, L.R.; Azziz, R. 1999: Dopamine D3 receptor polymorphism is not associated with the polycystic ovary syndrome. Fertility and Sterility 71(3): 436-438
Rietschel, M.; Krauss, H.; Müller, D.J.; Schulze, T.G.; Knapp, M.; Marwinski, K.; Maroldt, A.O.; Paus, S.; Grünhage, F.; Propping, P.; Maier, W.; Held, T.; Nöthen, M.M. 2000: Dopamine D3 receptor variant and tardive dyskinesia. European Archives of Psychiatry and Clinical Neuroscience 250(1): 31-35
Luippold, G.; Zimmermann, C.; Mai, M.; Kloor, D.; Starck, D.; Gross, G.; Mühlbauer, B. 2001: Dopamine D(3) receptors and salt-dependent hypertension. Journal of the American Society of Nephrology: Jasn 12(11): 2272-2279
Robinet, P.M.; Bardo, M.T. 2001: Dopamine D3 receptors are involved in amphetamine-induced contralateral rotation in 6-OHDA lesioned rats. Pharmacology Biochemistry and Behavior 70(1): 43-54
Diaz, J.; Pilon, C.; Le Foll, B.; Gros, C.; Triller, A.; Schwartz, J.C.; Sokoloff, P. 2000: Dopamine D3 receptors expressed by all mesencephalic dopamine neurons. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 20(23): 8677-8684
Mühlbauer, B.; Küster, E.; Luippold, G. 2000: Dopamine D(3) receptors in the rat kidney: role in physiology and pathophysiology. Acta Physiologica Scandinavica 168(1): 219-223
Yamada, S.; Harano, M.; Annoh, N.; Tanaka, M. 1999: Dopamine D(3) receptors modulate evoked dopamine release from slices of rat nucleus accumbens via muscarinic receptors, but not from the striatum. Journal of Pharmacology and Experimental Therapeutics 291(3): 994-998
Oak, J.N.; Lavine, N.; Van Tol, H.H. 2001: Dopamine D(4) and D(2L) Receptor Stimulation of the Mitogen-Activated Protein Kinase Pathway Is Dependent on trans-Activation of the Platelet-Derived Growth Factor Receptor. Molecular Pharmacology 60(1): 92-103
Faraone, S.V.; Biederman, J.; Weiffenbach, B.; Keith, T.; Chu, M.P.; Weaver, A.; Spencer, T.J.; Wilens, T.E.; Frazier, J.; Cleves, M.; Sakai, J. 1999: Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. American Journal of Psychiatry 156(5): 768-770
Price, C.J.; Pittman, Q.J. 2001: Dopamine D4 receptor activation inhibits presynaptically glutamatergic neurotransmission in the rat supraoptic nucleus. Journal of Neurophysiology 86(3): 1149-1155
Jentsch, J.D.; Taylor, J.R.; Redmond, D.E.; Elsworth, J.D.; Youngren, K.D.; Roth, R.H. 1999: Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys. Psychopharmacology 142(1): 78-84
Ricci, A.; Marchal-Victorion, S.; Bronzetti, E.; Parini, A.; Amenta, F.; Tayebati, S.K. 2002: Dopamine D4 receptor expression in rat kidney: evidence for pre- and postjunctional localization. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 50(8): 1091-1096
Bau, C.H.; Roman, T.; Almeida, S.; Hutz, M.H. 1999: Dopamine D4 receptor gene and personality dimensions in Brazilian male alcoholics. Psychiatric Genetics 9(3): 139-143
Persson, M.L.; Wasserman, D.; Geijer, T.; Frisch, A.; Rockah, R.; Michaelovsky, E.; Apter, A.; Weizman, A.; Jönsson, E.G.; Bergman, H. 2000: Dopamine D4 receptor gene polymorphism and personality traits in healthy volunteers. European Archives of Psychiatry and Clinical Neuroscience 250(4): 203-206
Paterson, A.D.; Sunohara, G.A.; Kennedy, J.L. 1999: Dopamine D4 receptor gene: novelty or nonsense?. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 21(1): 3-16
Rubinstein, M.; Cepeda, C.; Hurst, R.S.; Flores-Hernandez, J.; Ariano, M.A.; Falzone, T.L.; Kozell, L.B.; Meshul, C.K.; Bunzow, J.R.; Low, M.J.; Levine, M.S.; Grandy, D.K. 2001: Dopamine D4 receptor-deficient mice display cortical hyperexcitability. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 21(11): 3756-3763
Dulawa, S.C.; Grandy, D.K.; Low, M.J.; Paulus, M.P.; Geyer, M.A. 1999: Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 19(21): 9550-9556
Alfinito, P.D.; Townes-Anderson, E. 2001: Dopamine D4 receptor-mediated regulation of rod opsin mRNA expression in tiger salamander. Journal of Neurochemistry 76(3): 881-891
Helmeste, D.M.; Tang, S.W. 2000: Dopamine D4 receptors. Japanese Journal of Pharmacology 82(1): 1-14
Kulkarni, S.K.; Ninan, I. 2000: Dopamine D4 receptors and development of newer antipsychotic drugs. Fundamental and Clinical Pharmacology 14(6): 529-539
Rivera, A.; Cuéllar, B.; Girón, F.J.; Grandy, D.K.; de la Calle, A.; Moratalla, R. 2002: Dopamine D4 receptors are heterogeneously distributed in the striosomes/matrix compartments of the striatum. Journal of Neurochemistry 80(2): 219-229
Zhang, K.; Tarazi, F.I.; Baldessarini, R.J. 2000: Dopamine D(4) receptors in rat forebrain: unchanged with amphetamine-induced behavioral sensitization. Neuroscience 97(2): 211-213
Wang, X.; Zhong, P.; Yan, Z. 2002: Dopamine D4 receptors modulate GABAergic signaling in pyramidal neurons of prefrontal cortex. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 22(21): 9185-9193
Simpson, M.M.; Ballesteros, J.A.; Chiappa, V.; Chen, J.; Suehiro, M.; Hartman, D.S.; Godel, T.; Snyder, L.A.; Sakmar, T.P.; Javitch, J.A. 1999: Dopamine D4/D2 receptor selectivity is determined by A divergent aromatic microdomain contained within the second, third, and seventh membrane-spanning segments. Molecular Pharmacology 56(6): 1116-1126
Demchyshyn, L.L.; McConkey, F.; Niznik, H.B. 2000: Dopamine D5 receptor agonist high affinity and constitutive activity profile conferred by carboxyl-terminal tail sequence. Journal of Biological Chemistry 275(31): 23446-23455
Wang, J.; Liu, Z.L.; Chen, B. 2001: Dopamine D5 receptor gene polymorphism and the risk of levodopa-induced motor fluctuations in patients with Parkinson's disease. Neuroscience Letters 308(1): 21-24
Ciliax, B.J.; Nash, N.; Heilman, C.; Sunahara, R.; Hartney, A.; Tiberi, M.; Rye, D.B.; Caron, M.G.; Niznik, H.B.; Levey, A.I. 2000: Dopamine D(5) receptor immunolocalization in rat and monkey brain. Synapse 37(2): 125-145
Khan, Z.U.; Gutiérrez, A.; Martín, R.; Peñafiel, A.; Rivera, A.; de la Calle, A. 2000: Dopamine D5 receptors of rat and human brain. Neuroscience 100(4): 689-699
Bartrés-Faz, D.; Junqué, C.; Serra-Grabulosa, J.M.; López-Alomar, A.; Moya, A.; Bargalló, Núria.; Mercader, J.M.; Moral, P.; Clemente, I.C. 2002: Dopamine DRD2 Taq I polymorphism associates with caudate nucleus volume and cognitive performance in memory impaired subjects. Neuroreport 13(9): 1121-1125
Ray, M.R.; Lakshmi, C.; Deb, C.; Pal, B. 2000: Dopamine accelerates recovery from cyclophosphamide-induced leukopenia. Eksperimental'naya Onkologiya 22(3): 153-156
Scheller, C.; Sopper, S.; Jassoy, C.; Ter Meulen, V.; Riederer, P.; Koutsilieri, E. 2000: Dopamine activates HIV in chronically infected T lymphoblasts: Rapid communication. Journal of Neural Transmission 107(12): 1483-1489
Uchida, S.; Akaike, N.; Nabekura, J. 2000: Dopamine activates inward rectifier K+ channel in acutely dissociated rat substantia nigra neurones. Neuropharmacology 39(2): 191-201
Wersinger, S.R.; Rissman, E.F. 2000: Dopamine activates masculine sexual behavior independent of the estrogen receptor alpha. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 20(11): 4248-4254
Cornil, C.A.; Balthazart, J.; Motte, P.; Massotte, L.; Seutin, V. 2002: Dopamine activates noradrenergic receptors in the preoptic area. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 22(21): 9320-9330
Magoski, N.S.; Bulloch, A.G. 1999: Dopamine activates two different receptors to produce variability in sign at an identified synapse. Journal of Neurophysiology 81(3): 1330-1340
Piomelli, D.; Giuffrida, A.; Parsons, L.H.; Rodriguez, D.F.nseca, F.; Navarro, M. 1999: Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Prostaglandins and Other Lipid Mediators 59(1-6): 51
Hu, M.C.; Fan, L.; Crowder, L.A.; Karim-Jimenez, Z.; Murer, H.; Moe, O.W. 2001: Dopamine acutely stimulates Na+/H+ exchanger (NHE3) endocytosis via clathrin-coated vesicles: dependence on protein kinase A-mediated NHE3 phosphorylation. Journal of Biological Chemistry 276(29): 26906-26915
Porter, L.L.; Rizzo, E.; Hornung, J.P. 1999: Dopamine affects parvalbumin expression during cortical development in vitro. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 19(20): 8990-9003
Reuter, M.; Netter, P.; Toll, C.; Hennig, J. 2002: Dopamine agonist and antagonist responders as related to types of nicotine craving and facets of extraversion. Progress in Neuro-Psychopharmacology and Biological Psychiatry 26(5): 845-853
Swerdlow, N.R.; Eastvold, A.; Karban, B.; Ploum, Y.; Stephany, N.; Geyer, M.A.; Cadenhead, K.; Auerbach, P.P. 2002: Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies. Psychopharmacology 161(2): 189-201
Boraud, T.; Bezard, E.; Bioulac, B.; Gross, C.E. 2001: Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey. Brain: a Journal of Neurology 124(Part 3): 546-557
Ruskin, D.N.; Bergstrom, D.A.; Mastropietro, C.W.; Twery, M.J.; Walters, J.R. 1999: Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei. Neuroscience 91(3): 935-946
Schapira, A.H.V. 2002: Dopamine agonists and neuroprotection in Parkinson's disease. European Journal of Neurology 9(Suppl 3): 7-14
Cantor, C.R.; Stern, M.B. 2002: Dopamine agonists and sleep in Parkinson's disease. Neurology 58(4 Suppl 1): S71-S78
Chang, A.; Shin, S.H. 1999: Dopamine agonists both stimulate and inhibit prolactin release in GH4ZR7 cells. European Journal of Endocrinology 141(4): 387-395
Grujic, Z.; Mapstone, M.; Gitelman, D.R.; Johnson, N.; Weintraub, S.; Hays, A.; Kwasnica, C.; Harvey, R.; Mesulam, M.M. 1998: Dopamine agonists reorient visual exploration away from the neglected hemispace. Neurology 51(5): 1395-1398
Brooks, D.J. 2000: Dopamine agonists: their role in the treatment of Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry 68(6): 685-689
Rascol, O. 1999: Dopamine agonists: what is the place of the newer compounds in the treatment of Parkinson's disease?. Journal of Neural Transmission. Supplementum 55: 33-45
Cartmell, J.; Salhoff, C.R.; Perry, K.W.; Monn, J.A.; Schoepp, D.D. 2000: Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum. Brain Research 887(2): 378-384, 29 December
Lin, J.Y.; Yen, S.H.; Shieh, K.R.; Liang, S.L.; Pan, J.T. 2000: Dopamine and 7-OH-DPAT may act on D(3) receptors to inhibit tuberoinfundibular dopaminergic neurons. Brain Research Bulletin 52(6): 567-572
Tanaka, M.; Yoshida, T.; Okamoto, K.; Hirai, S. 1999: Dopamine and DOPA cause release of iron from ferritin and lipid peroxidation of liposomes. Neuroreport 10(9): 1883-1887
Kombian, S.B.; Ananthalakshmi, K.V.V.; Parvathy, S.S.; Matowe, W.C. 2003: Dopamine and adenosine mediate substance P-induced depression of evoked IPSCs in the rat nucleus accumbens in vitro. European Journal of Neuroscience 18(2): 303-311
Walter, H.; Ramskogler, K.; Semler, B.; Lesch, O.M.; Platz, W. 2001: Dopamine and alcohol relapse: D1 and D2 antagonists increase relapse rates in animal studies and in clinical trials. Journal of Biomedical Science 8(1): 83-88
Sopchak, D.; Miller, B.; Kalish, R.; Avyigal, Y.; Shi, X. 2002: Dopamine and ascorbate analysis at hydrodynamic electrodes of boron doped diamond and nitrogen incorporated tetrahedral amorphous carbon. Electroanalysis 14(7-8): 473-478
Calabresi, P.; Gubellini, P.; Centonze, D.; Picconi, B.; Bernardi, G.; Chergui, K.; Svenningsson, P.; Fienberg, A.A.; Greengard, P. 2000: Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 20(22): 8443-8451
Kozicz, Tás. 2003: Dopamine and cyclic AMP-regulated phosphoprotein immunoreactive neurons are innervated by axon terminals immunopositive for vasoactive intestinal polypeptide in the bed nuclei of the stria terminalis and central nucleus of the amygdala. Brain Research 962(1-2): 237-243
Berke, J.D.; Sgambato, V.; Zhu, P.P.; Lavoie, B.; Vincent, M.; Krause, M.; Hyman, S.E. 2001: Dopamine and glutamate induce distinct striatal splice forms of ania-6, an RNA polymerase II-associated cyclin. Neuron 32(2): 277-287
Jacobsson, S.O.; Fowler, C.J. 1999: Dopamine and glutamate neurotoxicity in cultured chick telencephali cells: Effects of NMDA antagonists, antioxidants and MAO inhibitors. Neurochemistry International 34(1): 49-62
You, Z.B.; Chen, Y.Q.; Wise, R.A. 2001: Dopamine and glutamate release in the nucleus accumbens and ventral tegmental area of rat following lateral hypothalamic self-stimulation. Neuroscience 107(4): 629-639
Floresco, S.B.; Phillips, A.G. 1999: Dopamine and hippocampal input to the nucleus accumbens play an essential role in the search for food in an unpredictable environment. Psychobiology 27(2): 277-286
Pulver, S.R.; Thirumalai, V.; Richards, K.S.; Marder, E. 2003: Dopamine and histamine in the developing stomatogastric system of the lobster Homarus americanus. Journal of Comparative Neurology 462(4): 400-414
Rihet, P.; Possamaï, C-Aimé.; Micallef-Roll, Jëlle.; Blin, O.; Hasbroucq, T. 2002: Dopamine and human information processing: a reaction-time analysis of the effect of levodopa in healthy subjects. Psychopharmacology 163(1): 62-67
Giuliano, F.; Allard, J. 2001: Dopamine and male sexual function. European Urology 40(6): 601-608
Sita, L.V.; Elias, C.F.; Bittencourt, J.C. 2003: Dopamine and melanin-concentrating hormone neurons are distinct populations in the rat rostromedial zona incerta. Brain Research 970(1-2): 232-237
Haamedi, S.N.; Djamgoz, M.B.A. 2002: Dopamine and nitric oxide control both flickering and steady-light-induced cone contraction and horizontal cell spinule formation in the teleost (carp) retina: serial interaction of dopamine and nitric oxide. Journal of Comparative Neurology 449(2): 120-128
Feenstra, M.G.; Botterblom, M.H.; Mastenbroek, S. 2000: Dopamine and noradrenaline efflux in the prefrontal cortex in the light and dark period: Effects of novelty and handling and comparison to the nucleus accumbens. Neuroscience 100(4): 741-748
Feenstra, M.G.; Vogel, M.; Botterblom, M.H.; Joosten, R.N.; de Bruin, J.P. 2001: Dopamine and noradrenaline efflux in the rat prefrontal cortex after classical aversive conditioning to an auditory cue. European Journal of Neuroscience 13(5): 1051-1054
Feenstra, M.G.; Teske, G.; Botterblom, M.H.; De Bruin, J.P. 1999: Dopamine and noradrenaline release in the prefrontal cortex of rats during classical aversive and appetitive conditioning to a contextual stimulus: Interference by novelty effects. Neuroscience Letters 272(3): 179-182
Neckameyer, W.S.; Woodrome, S.; Holt, B.; Mayer, A. 2000: Dopamine and senescence in Drosophila melanogaster. Neurobiology of Aging 21(1): 145-152
Neckameyer, W.; O'donnell, J.; Huang, Z.; Stark, W. 2001: Dopamine and sensory tissue development in Drosophila melanogaster. Journal of Neurobiology 47(4): 280-294
Duval, F.; Mokrani, M-Claude.; Monreal, Jé.; Bailey, P.; Valdebenito, M.; Crocq, M-Antoine.; Macher, J-Paul. 2003: Dopamine and serotonin function in untreated schizophrenia: Clinical correlates of the apomorphine and d-fenfluramine tests. Psychoneuroendocrinology 28(5): 627-642
Heidbreder, C.A.; Oertle, T.; Feldon, J. 1999: Dopamine and serotonin imbalances in the left anterior cingulate and pyriform cortices following the repeated intermittent administration of cocaine. Neuroscience 89(3): 701-715
Gervais, J.; Soghomonian, J.J.; Richard, D.; Rouillard, C. 1999: Dopamine and serotonin interactions in the modulation of the expression of the immediate-early transcription factor, nerve growth factor-inducible B, in the striatum. Neuroscience 91(3): 1045-1054
Kiss, T.; Hiripi, L.; Papp, N.; Elekes, K. 2003: Dopamine and serotonin receptors mediating contractions of the snail, Helix Pomatia, salivary duct. Neuroscience 116(3): 775-790
Yoshimoto, K.; Kato, B.; Ueda, S.; Noritake, K.; Sakai, K.; Shibata, M.; Hori, M.; Kawano, H.; Takeuchi, Y.; Wakabayashi, Y.; Yasuhara, M. 2001: Dopamine and serotonin uptake inhibitors on the release of dopamine and serotonin in the nucleus accumbens of young and aged rats. Mechanisms of Ageing and Development 122(15): 1707-1721
Arbuthnott, G.W.; Ingham, C.A.; Wickens, J.R. 2000: Dopamine and synaptic plasticity in the neostriatum. Journal of Anatomy 196: 587-596
Lee, A.C.; Harris, J.P.; Atkinson, E.A.; Nithi, K.; Fowler, M.S. 2002: Dopamine and the representation of the upper visual field: Evidence from vertical bisection errors in unilateral Parkinson's disease. Neuropsychologia 40(12): 2023-2029
López, H.H.; Ettenberg, A. 2001: Dopamine antagonism attenuates the unconditioned incentive value of estrous female cues. Pharmacology Biochemistry and Behavior 68(3): 411-416
Besheer, J.; Jensen, H.C.; Bevins, R.A. 1999: Dopamine antagonism in a novel-object recognition and a novel-object place conditioning preparation with rats. Behavioural Brain Research 103(1): 35-44
Salamone, J.D.; Arizzi, M.N.; Sandoval, M.D.; Cervone, K.M.; Aberman, J.E. 2002: Dopamine antagonists alter response allocation but do not suppress appetite for food in rats: contrast between the effects of SKF 83566, raclopride, and fenfluramine on a concurrent choice task. Psychopharmacology 160(4): 371-380
Wang, P.S.; Walker, A.M.; Tsuang, M.T.; Orav, E.John.; Glynn, R.J.; Levin, R.; Avorn, J. 2002: Dopamine antagonists and the development of breast cancer. Archives of General Psychiatry 59(12): 1147-1154
Byrnes, E.M.; Rigero, B.A.; Bridges, R.S. 2002: Dopamine antagonists during parturition disrupt maternal care and the retention of maternal behavior in rats. Pharmacology Biochemistry and Behavior 73(4): 869-875
Zavitsanou, K.; Cranney, J.; Richardson, R. 1999: Dopamine antagonists in the orbital prefrontal cortex reduce prepulse inhibition of the acoustic startle reflex in the rat. Pharmacology Biochemistry and Behavior 63(1): 55-61
Yasunari, K.; Maeda, K.; Nakamura, M.; Yoshikawa, J. 2003: Dopamine as a novel anti-migration factor of vascular smooth muscle cells through D1A and D1B receptors. Journal of Cardiovascular Pharmacology 41(Suppl 1): S33-S38
Yasunari, K.; Kohno, M.; Kano, H.; Minami, M.; Yoshikawa, J. 2000: Dopamine as a novel antioxidative agent for rat vascular smooth muscle cells through dopamine D(1)-like receptors. Circulation 101(19): 2302-2308
Rosenkranz, J.A.; Grace, A.A. 2001: Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 21(11): 4090-4103
Ekesbo, A.; Rydin, E.; Torstenson, R.; Sydow, O.; Låengström, B.; Tedroff, J. 1999: Dopamine autoreceptor function is lost in advanced Parkinson's disease. Neurology 52(1): 120-125
Joseph, J.D.; Wang, Y-M.; Miles, P.R.; Budygin, E.A.; Picetti, R.; Gainetdinov, R.R.; Caron, M.G.; Wightman, R.M. 2002: Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of D(3) receptors. Neuroscience 112(1): 39-49
Alaniz, R.C.; Thomas, S.A.; Perez-Melgosa, M.; Mueller, K.; Farr, A.G.; Palmiter, R.D.; Wilson, C.B. 1999: Dopamine beta-hydroxylase deficiency impairs cellular immunity. Proceedings of the National Academy of Sciences of the United States of America 96(5): 2274-2278
Slama, P.; Jabre, F.; Tron, T.; Réglier, M. 2001: Dopamine beta-hydroxylase inactivation generates a protein-bound quinone derivative. Febs Letters 491(1-2): 55-58
Oyarce, A.M.; Steveson, T.C.; Jin, L.; Eipper, B.A. 2001: Dopamine beta-monooxygenase signal/anchor sequence alters trafficking of peptidylglycine alpha-hydroxylating monooxygenase. Journal of Biological Chemistry 276(35): 33265-33272
Rodríguez, M.; Barroso-Chinea, P.; Abdala, P.; Obeso, J.; González-Hernández, T. 2001: Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in parkinson's disease. Experimental Neurology 169(1): 163-181
Sinclair, S.R.; Fawcett, J.W.; Dunnett, S.B. 1999: Dopamine cells in nigral grafts differentiate prior to implantation. European Journal of Neuroscience 11(12): 4341-4348
de Bruin, N.M.; van Luijtelaar, E.L.; Jansen, S.J.; Cools, A.R.; Ellenbroek, B.A. 2000: Dopamine characteristics in different rat genotypes: The relation to absence epilepsy. Neuroscience Research 38(2): 165-173
de Bruin, N.M.; van Luijtelaar, E.L.; Cools, A.R.; Ellenbroek, B.A. 2001: Dopamine characteristics in rat genotypes with distinct susceptibility to epileptic activity: apomorphine-induced stereotyped gnawing and novelty/amphetamine-induced locomotor stimulation. Behavioural Pharmacology 12(6-7): 517-525
Fauchey, V.; Jaber, M.; Bloch, B.; Le Moine, C. 2000: Dopamine control of striatal gene expression during development: Relevance to knockout mice for the dopamine transporter. European Journal of Neuroscience 12(9): 3415-3425
Tanaka, S. 2002: Dopamine controls fundamental cognitive operations of multi-target spatial working memory. Neural Networks: the Official Journal of the International Neural Network Society 15(4-6): 573-582
Jaliffa, C.O.; Lacoste, F.F.; Llomovatte, D.W.; Sarmiento, M.I.; Rosenstein, R.E. 2000: Dopamine decreases melatonin content in golden hamster retina. Journal of Pharmacology and Experimental Therapeutics 293(1): 91-95
Gulledge, A.T.; Jaffe, D.B. 1998: Dopamine decreases the excitability of layer V pyramidal cells in the rat prefrontal cortex. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 18(21): 9139-9151
Kobayashi, K.; Sano, H. 2000: Dopamine deficiency in mice. Brain and Development 22(Suppl): S54-S60
Levein, N.G.; Thörn, S.E.; Wattwil, M. 1999: Dopamine delays gastric emptying and prolongs orocaecal transit time in volunteers. European Journal of Anaesthesiology 16(4): 246-250
Florio, T.; Capozzo, A.; Nisini, A.; Lupi, A.; Scarnati, E. 1999: Dopamine denervation of specific striatal subregions differentially affects preparation and execution of a delayed response task in the rat. Behavioural Brain Research 104(1-2): 51-62
Brown, P.; Oliviero, A.; Mazzone, P.; Insola, A.; Tonali, P.; Di Lazzaro, V. 2001: Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 21(3): 1033-1038
Balcioglu, A.; Zhang, K.; Tarazi, F.I. 2003: Dopamine depletion abolishes apomorphine- and amphetamine-induced increases in extracellular serotonin levels in the striatum of conscious rats: A microdialysis study. Neuroscience 119(4): 1045-1053
Cho, J.; Duke, D.; Manzino, L.; Sonsalla, P.K.; West, M.O. 2002: Dopamine depletion causes fragmented clustering of neurons in the sensorimotor striatum: evidence of lasting reorganization of corticostriatal input. Journal of Comparative Neurology 452(1): 24-37
Beyer, C.E.; Steketee, J.D. 1999: Dopamine depletion in the medial prefrontal cortex induces sensitized-like behavioral and neurochemical responses to cocaine. Brain Research 833(2): 133-141
Powell, S.B.; Geyer, M.A.; Preece, M.A.; Pitcher, L.K.; Reynolds, G.P.; Swerdlow, N.R. 2003: Dopamine depletion of the nucleus accumbens reverses isolation-induced deficits in prepulse inhibition in rats. Neuroscience 119(1): 233-240
Fan, S.F.; Yazulla, S. 2001: Dopamine depletion with 6-OHDA enhances dopamine D1-receptor modulation of potassium currents in retinal bipolar cells. Visual Neuroscience 18(2): 327-337
Bek, M.; Fischer, K.G.; Greiber, S.; Hupfer, C.; Mundel, P.; Pavenstädt, H. 1999: Dopamine depolarizes podocytes via a D1-like receptor. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 14(3): 581-587
Behr, J.; Gloveli, T.; Schmitz, D.; Heinemann, U. 2000: Dopamine depresses excitatory synaptic transmission onto rat subicular neurons via presynaptic D1-like dopamine receptors. Journal of Neurophysiology 84(1): 112-119
Chen, X.; Kombian, S.B.; Zidichouski, J.A.; Pittman, Q.J. 1999: Dopamine depresses glutamatergic synaptic transmission in the rat parabrachial nucleus in vitro. Neuroscience 90(2): 457-468
Behr, J.; Gloveli, T.; Schmitz, D.; Heinemann, U. 2000: Dopamine depresses polysynaptic inhibition in rat subicular neurons. Brain Research 861(1): 160-164
Hsia, A.Y.; Vincent, J.D.; Lledo, P.M. 1999: Dopamine depresses synaptic inputs into the olfactory bulb. Journal of Neurophysiology 82(2): 1082-1085
Seeman, P.; Tallerico, T.; Ko, F. 2003: Dopamine displaces (3H)domperidone from high-affinity sites of the dopamine D2 receptor, but not (3H)raclopride or (3H)spiperone in isotonic medium: Implications for human positron emission tomography. Synapse (New York) 49(4): 209-215
Solanto, M.V. 2002: Dopamine dysfunction in AD/HD: Integrating clinical and basic neuroscience research. Behavioural Brain Research 130(1-2): 65-71
Elkashef, A.M.; Al-Barazi, H.; Venable, D.; Baker, I.; Hill, J.; Apud, J.; Wyatt, R.Jed. 2002: Dopamine effect on the mitochondria potential in B lymphocytes of schizophrenic patients and normal controls. Progress in Neuro-Psychopharmacology and Biological Psychiatry 26(1): 145-148
Liu, Y.; Luo, F-Jun.; Liang, P-Ji. 2003: Dopamine effect on the stimulus pattern related changes in response characteristics of R/G horizontal cells in carp retina. Brain Research 973(2): 190-195
Obata, T. 2002: Dopamine efflux by MPTP and hydroxyl radical generation. Journal of Neural Transmission 109(9): 1159-1180
Itokawa, M.; Lin, Z.; Uhl, G.R. 2002: Dopamine efflux via wild-type and mutant dopamine transporters: Alanine substitution for proline-572 enhances efflux and reduces dependence on extracellular dopamine, sodium and chloride concentrations. Brain Research. Molecular Brain Research 108(1-2): 71-80
Flores-Hernández, J.; Cepeda, C.; Hernández-Echeagaray, E.; Calvert, C.R.; Jokel, E.S.; Fienberg, A.A.; Greengard, P.; Levine, M.S. 2002: Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32. Journal of Neurophysiology 88(6): 3010-3020
Gonzalez-Islas, C.; Hablitz, J.J. 2003: Dopamine enhances EPSCs in layer II-IIi pyramidal neurons in rat prefrontal cortex. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 23(3): 867-875
Berndt, T.J.; Tucker, R.R.; Kent, P.D.; Streiff, P.C.; Tyce, G.M.; Knox, F.G. 1999: Dopamine enhances the phosphaturic effect of PTH during acute respiratory alkalosis. Journal of Laboratory and Clinical Medicine 134(6): 616-622
Bracci, E.; Centonze, D.; Bernardi, G.; Calabresi, P. 2002: Dopamine excites fast-spiking interneurons in the striatum. Journal of Neurophysiology 87(4): 2190-2194
Hussain, T.; Becker, M.; Beheray, S.; Lokhandwala, M.F. 2001: Dopamine fails to inhibit Na,H-exchanger in proximal tubules of obese Zucker rats. Clinical and Experimental Hypertension 23(8): 591-601
Ranaldi, R.; Pocock, D.; Zereik, R.; Wise, R.A. 1999: Dopamine fluctuations in the nucleus accumbens during maintenance, extinction, and reinstatement of intravenous D-amphetamine self-administration. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 19(10): 4102-4109
Maleck, W.H.; Piper, S.N.; Koetter, K.P. 2003: Dopamine for renal protection. Canadian Journal of Anaesthesia 50(1): 93
Nyhan, W.L. 2000: Dopamine function in Lesch-Nyhan disease. Environmental Health Perspectives 108(Suppl): 409-411
Brambilla, F.; Perna, G.; Bussi, R.; Bellodi, L. 2000: Dopamine function in obsessive compulsive disorder: Cortisol response to acute apomorphine stimulation. Psychoneuroendocrinology 25(3): 301-310
O'Donnell, P. 2003: Dopamine gating of forebrain neural ensembles. European Journal of Neuroscience 17(3): 429-435
Horvitz, J.C. 2002: Dopamine gating of glutamatergic sensorimotor and incentive motivational input signals to the striatum. Behavioural Brain Research 137(1-2): 65-74
DiMaio, S.; Grizenko, N.; Joober, R. 2003: Dopamine genes and attention-deficit hyperactivity disorder: a review. Journal of Psychiatry and Neuroscience: Jpn 28(1): 27-38
Ogilvie, J.Mosinger.; Speck, J.D. 2002: Dopamine has a critical role in photoreceptor degeneration in the rd mouse. Neurobiology of Disease 10(1): 33-40
Heinz, A. 2000: Dopamine hypothesis of schizophrenia. New findings support a traditional theory. Nervenarzt 71(1): 54-57
Brownell, A.L.; Jenkins, B.G.; Isacson, O. 1999: Dopamine imaging markers and predictive mathematical models for progressive degeneration in Parkinson's disease. Biomedicine and PharmacoTherapy 53(3): 131-140
Marai, I.; Levi, Y. 2001: Dopamine in acute renal failure. Harefuah 140(7): 644-7 677
Smit, A.J. 2000: Dopamine in heart failure and critical care. Clinical and Experimental Hypertension 22(3): 269-276
Svennilson, J.; Aperia, A. 1999: Dopamine in the developing kidney. International Journal of Developmental Biology 43(5): 441-443
Kiyatkin, E.A. 2002: Dopamine in the nucleus accumbens: Cellular actions, drug- and behavior-associated fluctuations, and a possible role in an organism's adaptive activity. Behavioural Brain Research 137(1-2): 27-46
Deransart, C.; Riban, V.; Lê, B.; Marescaux, C.; Depaulis, A. 2000: Dopamine in the striatum modulates seizures in a genetic model of absence epilepsy in the rat. Neuroscience 100(2): 335-344
Henze, D.A.; González-Burgos, G.R.; Urban, N.N.; Lewis, D.A.; Barrionuevo, G. 2000: Dopamine increases excitability of pyramidal neurons in primate prefrontal cortex. Journal of Neurophysiology 84(6): 2799-2809
Khan, F.H.; Saha, M.; Chakrabarti, S. 2001: Dopamine induced protein damage in mitochondrial-synaptosomal fraction of rat brain. Brain Research 895(1-2): 245-249
Vindis, C.; Séguélas, M.H.; Lanier, S.; Parini, A.; Cambon, C. 2001: Dopamine induces ERK activation in renal epithelial cells through H2O2 produced by monoamine oxidase. Kidney International 59(1): 76-86
Brami-Cherrier, K.; Valjent, E.; Garcia, M.; Pagès, C.; Hipskind, R.A.; Caboche, J. 2002: Dopamine induces a PI3-kinase-independent activation of Akt in striatal neurons: a new route to cAMP response element-binding protein phosphorylation. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 22(20): 8911-8921
Ray, M.-Ranjan; Lahiri, T. 2000: Dopamine induces apoptosis in murine tumor cells in vivo. Biogenic Amines 16(1): 21-28
Gómez-Santos, C.; Ferrer, I.; Santidrián, A.F.; Barrachina, M.; Gil, J.; Ambrosio, S. 2003: Dopamine induces autophagic cell death and alpha-synuclein increase in human neuroblastoma SH-SY5Y cells. Journal of Neuroscience Research 73(3): 341-350
Rey, E.; Hernández-Díaz, F.J.; Abreu, P.; Alonso, R.; Tabares, L. 2001: Dopamine induces intracellular Ca2+ signals mediated by alpha1B-adrenoceptors in rat pineal cells. European Journal of Pharmacology 430(1): 9-17
Sookhai, S.; Wang, J.H.; Mccourt, M.; O'connell, D.; Redmond, H.P. 1999: Dopamine induces neutrophil apoptosis through a dopamine D-1 receptor-independent mechanism. Surgery 126(2): 314-322
Keller, J.N.; Huang, F.F.; Dimayuga, E.R.; Maragos, W.F. 2000: Dopamine induces proteasome inhibition in neural PC12 cell line. Free Radical Biology and Medicine 29(10): 1037-1042
Berger, S.P.; Hünger, M.; Yard, B.A.; Schnuelle, P.; Van Der Woude, F.J. 2000: Dopamine induces the expression of heme oxygenase-1 by human endothelial cells in vitro. Kidney International 58(6): 2314-2319
Ruel, J.; Nouvian, R.; Gervais d'Aldin, C.; Pujol, R.; Eybalin, M.; Puel, J.L. 2001: Dopamine inhibition of auditory nerve activity in the adult mammalian cochlea. European Journal of Neuroscience 14(6): 977-986
Gonzalez-Islas, C.; Hablitz, J.J. 2001: Dopamine inhibition of evoked IPSCs in rat prefrontal cortex. Journal of Neurophysiology 86(6): 2911-2918
Nakashima, A.; Mori, K.; Suzuki, T.; Kurita, H.; Otani, M.; Nagatsu, T.; Ota, A. 1999: Dopamine inhibition of human tyrosine hydroxylase type 1 is controlled by the specific portion in the N-terminus of the enzyme. Journal of Neurochemistry 72(5): 2145-2153
Alcayaga, J.; Retamal, M.; Cerpa, Vónica.; Arroyo, J.; Zapata, P. 2003: Dopamine inhibits ATP-induced responses in the cat petrosal ganglion in vitro. Brain Research 966(2): 283-287
Beheray, S.A.; Hussain, T.; Lokhandwala, M.F. 2000: Dopamine inhibits na,h-exchanger via D1-like receptor-mediated stimulation of protein kinase a in renal proximal tubules. Clinical and Experimental Hypertension 22(6): 635-644
Ghosh, M.C.; Mondal, A.C.; Basu, S.; Banerjee, S.; Majumder, J.; Bhattacharya, D.; Dasgupta, P.S. 2003: Dopamine inhibits cytokine release and expression of tyrosine kinases, Lck and Fyn in activated T cells. International Immunopharmacology 3(7): 1019-1026
Tosini, G.; Dirden, J.C. 2000: Dopamine inhibits melatonin release in the mammalian retina: In vitro evidence. Neuroscience Letters 286(2): 119-122
Kunimi, M.; Seki, G.; Hara, C.; Taniguchi, S.; Uwatoko, S.; Goto, A.; Kimura, S.; Fujita, T. 2000: Dopamine inhibits renal Na+:HCO3- cotransporter in rabbits and normotensive rats but not in spontaneously hypertensive rats. Kidney International 57(2): 534-543
Edwards, R.M.; Brooks, D.P. 2001: Dopamine inhibits vasopressin action in the rat inner medullary collecting duct via alpha(2)-adrenoceptors. Journal of Pharmacology and Experimental Therapeutics 298(3): 1001-1006
Sesack, S.R.; Hawrylak, V.A.; Melchitzky, D.S.; Lewis, D.A. 1998: Dopamine innervation of a subclass of local circuit neurons in monkey prefrontal cortex: ultrastructural analysis of tyrosine hydroxylase and parvalbumin immunoreactive structures. Cerebral Cortex 8(7): 614-622
Erickson, S.L.; Sesack, S.R.; Lewis, D.A. 2000: Dopamine innervation of monkey entorhinal cortex: postsynaptic targets of tyrosine hydroxylase-immunoreactive terminals. Synapse 36(1): 47-56
Levite, M.; Chowers, Y.; Ganor, Y.; Besser, M.; Hershkovits, R.; Cahalon, L. 2001: Dopamine interacts directly with its D3 and D2 receptors on normal human T cells, and activates beta1 integrin function. European Journal of Immunology 31(12): 3504-3512
Furutama, K.; Sakuma, Y.; Kato, Y.; Tamura, M.; Mori, N.; Oka, M.; Yoshikawa, H.; Ueda, Y. 1999: Dopamine matabolism during orofacial pain in the rat prefrontal cortex. Shika Igaku 62(4): 197-200
Oades, R.D. 2002: Dopamine may be 'hyper' with respect to noradrenaline metabolism, but 'hypo' with respect to serotonin metabolism in children with attention-deficit hyperactivity disorder. Behavioural Brain Research 130(1-2): 97-102
Takamatsu, I.; Karasawa, F.; Okuda, T. 2002: Dopamine may preserve the myocardial oxygen balance better than dobutamine when administered with milrinone. Canadian Journal of Anaesthesia 49(9): 968-972
Ribelayga, C.; Wang, Y.; Mangel, S.C. 2002: Dopamine mediates circadian clock regulation of rod and cone input to fish retinal horizontal cells. Journal of Physiology 544(3): 801-816
Manglapus, M.K.; Iuvone, P.M.; Underwood, H.; Pierce, M.E.; Barlow, R.B. 1999: Dopamine mediates circadian rhythms of rod-cone dominance in the Japanese quail retina. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 19(10): 4132-4141
Xia, X.G.; Schmidt, N.; Teismann, P.; Ferger, B.; Schulz, J.B. 2001: Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation. Journal of Neurochemistry 79(1): 63-70
Roitman, M.F.; Van Dijk, G.; Thiele, T.E.; Bernstein, I.L. 2001: Dopamine mediation of the feeding response to violations of spatial and temporal expectancies. Behavioural Brain Research 122(2): 193-199
Okada, Y.; Miyamoto, T.; Toda, K. 2003: Dopamine modulates a voltage-gated calcium channel in rat olfactory receptor neurons. Brain Research 968(2): 248-255
Bainton, R.J.; Tsai, L.T.; Singh, C.M.; Moore, M.S.; Neckameyer, W.S.; Heberlein, U. 2000: Dopamine modulates acute responses to cocaine, nicotine and ethanol in Drosophila. Current Biology: Cb 10(4): 187-194
Alcayaga, J.; Varas, R.; Arroyo, J.; Iturriaga, R.; Zapata, P. 1999: Dopamine modulates carotid nerve responses induced by acetylcholine on the cat petrosal ganglion in vitro. Brain Research 831(1-2): 97-103
Ohtani, N.; Goto, T.; Waeber, C.; Bhide, P.G. 2003: Dopamine modulates cell cycle in the lateral ganglionic eminence. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 23(7): 2840-2850
Ding, L.; Perkel, D.J. 2002: Dopamine modulates excitability of spiny neurons in the avian basal ganglia. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 22(12): 5210-5218
Mansvelder, H.D.; Lodder, J.C.; Sons, M.èl.S.; Kits, K.S. 2002: Dopamine modulates exocytosis independent of Ca(2+) entry in melanotropic cells. Journal of Neurophysiology 87(2): 793-801
Kähkönen, S.; Ahveninen, J.; Pekkonen, E.; Kaakkola, S.; Huttunen, J.; Ilmoniemi, R.J.; Jääskeläinen, I.P. 2002: Dopamine modulates involuntary attention shifting and reorienting: An electromagnetic study. Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology 113(12): 1894-1902
Vargas, G.; Lucero, M.T. 1999: Dopamine modulates inwardly rectifying hyperpolarization-activated current (Ih) in cultured rat olfactory receptor neurons. Journal of Neurophysiology 81(1): 149-158
El-Mas, M.M.; Elmallah, A.I.; Omar, A.G.; Sharabi, F. 1999: Dopamine modulates peripheral purinergic neurotransmission through multiple presynaptic receptors: tissue-dependent effects. Pharmacological Research 39(1): 11-19
Sun, W.; Salvi, R.J. 2001: Dopamine modulates sodium currents in cochlear spiral ganglion neurons. Neuroreport 12(4): 803-807
Davila, N.G.; Blakemore, L.J.; Trombley, P.Q. 2003: Dopamine modulates synaptic transmission between rat olfactory bulb neurons in culture. Journal of Neurophysiology 90(1): 395-404
Kline, D.D.; Takacs, K.N.; Ficker, E.; Kunze, D.L. 2002: Dopamine modulates synaptic transmission in the nucleus of the solitary tract. Journal of Neurophysiology 88(5): 2736-2744
Wittmann, M.; Marino, M.J.; Conn, P.J. 2002: Dopamine modulates the function of group Ii and group IIi metabotropic glutamate receptors in the substantia nigra pars reticulata. Journal of Pharmacology and Experimental Therapeutics 302(2): 433-441
Tessitore, A.; Hariri, A.R.; Fera, F.; Smith, W.G.; Chase, T.N.; Hyde, T.M.; Weinberger, D.R.; Mattay, V.S. 2002: Dopamine modulates the response of the human amygdala: a study in Parkinson's disease. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 22(20): 9099-9103
Lavin, A.; Grace, A.A. 1998: Dopamine modulates the responsivity of mediodorsal thalamic cells recorded in vitro. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 18(24): 10566-10578
Reynolds, D.S.; Carter, R.J.; Morton, A.J. 1998: Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 18(23): 10116-10127
Kloppenburg, P.; Levini, R.M.; Harris-Warrick, R.M. 1999: Dopamine modulates two potassium currents and inhibits the intrinsic firing properties of an identified motor neuron in a central pattern generator network. Journal of Neurophysiology 81(1): 29-38
Storozhuk, V.M.; Khorevin, V.I.; Rozumna, N.M.; Villa, A.E.P.; Tetko, I.V. 2002: Dopamine modulation of activity of cat sensorimotor cortex neurons during conditioned reflexes. Neuroscience Letters 330(2): 171-174
Zhou, F.M.; Hablitz, J.J. 1999: Dopamine modulation of membrane and synaptic properties of interneurons in rat cerebral cortex. Journal of Neurophysiology 81(3): 967-976
Onn, S.-P.; Fienberg, A.A.; Grace, A.A. 2003: Dopamine modulation of membrane excitability in striatal spiny neurons is altered in DARPP-32 knockout mice. Journal of Pharmacology and Experimental Therapeutics 306(3): 870-879
Gonzalez Burgos, G.; Kroner, S.; Krimer, L.S.; Seamans, J.K.; Urban, N.N.; Henze, D.A.; Lewis, D.A.; Barrionuevo, G. 2002: Dopamine modulation of neuronal function in the monkey prefrontal cortex. Physiology and Behavior 77(4-5): 537-543
Gao, W.-J.; Wang, Y.; Goldman-Rakic, P.S. 2003: Dopamine modulation of perisomatic and peridendritic inhibition in prefrontal cortex. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 23(5): 1622-1630
Jones, S.R.; Joseph, J.D.; Barak, L.S.; Caron, M.G.; Wightman, R.M. 1999: Dopamine neuronal transport kinetics and effects of amphetamine. Journal of Neurochemistry 73(6): 2406-2414
Eells, J.B.; Yeung, S.K.; Nikodem, V.M. 2002: Dopamine neurons heterozygous for the Nurr1-null allele have reduced survival in vitro. Neuroscience Research Communications 30(3): 173-183
Schatz, D.S.; Kaufmann, W.A.; Saria, A.; Humpel, C. 1999: Dopamine neurons in a simple GDNF-treated meso-striatal organotypic co-culture model. Experimental Brain Research 127(3): 270-278
Hollerman, J.R.; Schultz, W. 1998: Dopamine neurons report an error in the temporal prediction of reward during learning. Nature Neuroscience 1(3): 304-309
Cantuti-Castelvetri, I.; Shukitt-Hale, B.; Joseph, J.A. 2003: Dopamine neurotoxicity: Age-dependent behavioral and histological effects. Neurobiology of Aging 24(5): 697-706
Masi, F.; Scheggi, S.; Mangiavacchi, S.; Tolu, P.; Tagliamonte, A.; De Montis, M.G.; Gambarana, C. 2001: Dopamine output in the nucleus accumbens shell is related to the acquisition and the retention of a motivated appetitive behavior in rats. Brain Research 903(1-2): 102-109
Berman, S.B.; Hastings, T.G. 1999: Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: Implications for Parkinson's disease. Journal of Neurochemistry 73(3): 1127-1137
Khan, F.Hossain.; Sen, T.; Chakrabarti, S. 2003: Dopamine oxidation products inhibit Na+, K+-ATPase activity in crude synaptosomal-mitochondrial fraction from rat brain. Free Radical Research 37(6): 597-601
Orsini, C.; Koob, G.F.; Pulvirenti, L. 2001: Dopamine partial agonist reverses amphetamine withdrawal in rats. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 25(5): 789-792
Miyaguchi, H.; Kato, I.; Sano, T.; Sobajima, H.; Fujimoto, S.; Togari, H. 1999: Dopamine penetrates to the central nervous system in developing rats. Pediatrics International: Official Journal of the Japan Pediatric Society 41(4): 363-368
Ray, M.-Ranjan; Lakshmi, C.; Pal, B. 2000: Dopamine pretreatment in mice diminishes the hematotoxic effects of cyclophosphamide. Biogenic Amines 15(5): 465-475
Park, S.; Geddes, T.J.; Javitch, J.A.; Kuhn, D.M. 2003: Dopamine prevents nitration of tyrosine hydroxylase by peroxynitrite and nitrogen dioxide: is nitrotyrosine formation an early step in dopamine neuronal damage?. Journal of Biological Chemistry 278(31): 28736-28742
Szczypka, M.S.; Kwok, K.; Brot, M.D.; Marck, B.T.; Matsumoto, A.M.; Donahue, B.A.; Palmiter, R.D. 2001: Dopamine production in the caudate putamen restores feeding in dopamine-deficient mice. Neuron 30(3): 819-828
Féron, F.; Vincent, A.; Mackay-Sim, A. 1999: Dopamine promotes differentiation of olfactory neuron in vitro. Brain Research 845(2): 252-259
Loupe, P.S.; Bredemeier, J.D.; Schroeder, S.R.; Tessel, R.E. 2002: Dopamine re-uptake inhibitor GBR-12909 induction of aberrant behaviors in animal models of dopamine dysfunction. International Journal of Developmental Neuroscience: the Official Journal of the International Society for Developmental Neuroscience 20(3-5): 323-333
Serretti, A.; Macciardi, F.; Smeraldi, E. 1998: Dopamine receptor D2 Ser/Cys311 variant associated with disorganized symptomatology of schizophrenia. Schizophrenia Research 34(3): 207-210
Benedetti, F.; Serretti, A.; Colombo, C.; Lilli, R.; Lorenzi, C.; Smeraldi, E. 2003: Dopamine receptor D2 and D3 gene variants are not associated with the antidepressant effect of total sleep deprivation in bipolar depression. Psychiatry Research 118(3): 241-247
Serretti, A.; Lilli, R.; Lorenzi, C.; Franchini, L.; Di Bella, D.; Catalano, M.; Smeraldi, E. 1999: Dopamine receptor D2 and D4 genes, GABA(A) alpha-1 subunit genes and response to lithium prophylaxis in mood disorders. Psychiatry Research 87(1): 7-19
Pastor, P.; Muñoz, E.; Obach, V.; Martí, M.J.; Blesa, R.; Oliva, R.; Tolosa, E. 1999: Dopamine receptor D2 intronic polymorphism in patients with Parkinson's disease. Neuroscience Letters 273(3): 151-154
Serretti, A.; Lilli, R.; Di Bella, D.; Bertelli, S.; Nobile, M.; Novelli, E.; Catalano, M.; Smeraldi, E. 1999: Dopamine receptor D4 gene is not associated with major psychoses. American Journal of Medical Genetics 88(5): 486-491
Armentero, M-Thérèse.; Fancellu, R.; Nappi, G.; Blandini, F. 2002: Dopamine receptor agonists mediate neuroprotection in malonate-induced striatal lesion in the rat. Experimental Neurology 178(2): 301-305
Dwyer, D.S.; Liu, Y.; Bradley, R.J. 1999: Dopamine receptor antagonists modulate glucose uptake in rat pheochromocytoma (PC12) cells. Neuroscience Letters 274(3): 151-154
Bast, T.; Pezze, M.A.; Feldon, J. 2002: Dopamine receptor blockade in the rat medial prefrontal cortex reduces spontaneous and amphetamine-induced activity and does not affect prepulse inhibition. Behavioural Pharmacology 13(8): 669-673
Coronas, V.; Krantic, S.; Jourdan, F.; Moyse, E. 1999: Dopamine receptor coupling to adenylyl cyclase in rat olfactory pathway: A combined pharmacological-radioautographic approach. Neuroscience 90(1): 69-78
McKenna, F.; McLaughlin, P.J.; Lewis, B.J.; Sibbring, G.C.; Cummerson, J.A.; Bowen-Jones, D.; Moots, R.J. 2002: Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: A flow cytometric study. Journal of Neuroimmunology 132(1-2): 34-40
Wong, A.H.; Knapp, M.G.; Van Tol, H.H. 2000: Dopamine receptor gene transfer into rat striatum using a recombinant adenoviral vector: Rotational behaviour. Neuroscience Letters 291(3): 135-138
Shepherd, A.Graeme.; Lea, R.A.; Hutchins, C.; Jordan, K.L.; Brimage, P.J.; Griffiths, L.R. 2002: Dopamine receptor genes and migraine with and without aura: An association study. Headache 42(5): 346-351
Miller, W.B.; Pasta, D.J.; MacMurray, J.; Chiu, C.; Wu, H.; Comings, D.E. 1999: Dopamine receptor genes are associated with age at first sexual intercourse. Journal of Biosocial Science 31(1): 43-54
Tsai, S-Jen.; Hong, C-Jee. 2003: Dopamine receptor hetero-oligomerization: A hypothesis for behavioral sensitization to psychostimulants. Medical Hypotheses 61(1): 18-20
Mignini, F.; Bronzetti, E.; Felici, L.; Ricci, A.; Sabbatini, M.; Tayebati, S.K.; Amenta, F. 2000: Dopamine receptor immunohistochemistry in the rat choroid plexus. Journal of Autonomic Pharmacology 20(5-6): 325-332
Nguyen-Legros, J.; Versaux-Botteri, C.; Vernier, P. 1999: Dopamine receptor localization in the mammalian retina. Molecular Neurobiology 19(3): 181-204
Zarrindast, M-Reza.; Dinkoub, Z.; Homayoun, H.; Bakhtiarian, A.; Khavandgar, S. 2002: Dopamine receptor mechanism(s) and morphine tolerance in mice. Journal of Psychopharmacology 16(3): 261-266
Markianos, M.; Moussas, G.; Lykouras, L.; Hatzimanolis, J. 2000: Dopamine receptor responsivity in alcoholic patients before and after detoxification. Drug and Alcohol Dependence 57(3): 261-265
Lykouras, L.; Markianos, M.; Hatzimanolis, J.; Oulis, P. 2001: Dopamine receptor responsivity in schizophrenic patients in a drug-free state and after treatment with olanzapine. Progress in Neuro-Psychopharmacology and Biological Psychiatry 25(3): 507-518
Ninan, I.; Kulkarni, S.K. 1998: Dopamine receptor sensitive effect of dizocilpine on feeding behaviour. Brain Research 812(1-2): 157-163
Chandhoke, V.; Southall, M.; Holt, R.; Flinn, J.M. 2001: Dopamine receptor subtype density as a function of age in Aplysia californica. Comparative Biochemistry and Physiology. Part B Biochemistry and Molecular Biology 130(4): 461-466
Brünig, I.; Sommer, M.; Hatt, H.; Bormann, J. 1999: Dopamine receptor subtypes modulate olfactory bulb gamma-aminobutyric acid type A receptors. Proceedings of the National Academy of Sciences of the United States of America 96(5): 2456-2460
Bergson, C.; Levenson, R.; Goldman-Rakic, P.S.; Lidow, M.S. 2003: Dopamine receptor-interacting proteins: the Ca(2+) connection in dopamine signaling. Trends in Pharmacological Sciences 24(9): 486-492
Otani, S.; Auclair, N.; Desce, J.M.; Roisin, M.P.; Crépel, F. 1999: Dopamine receptors and groups i and Ii mGluRs cooperate for long-term depression induction in rat prefrontal cortex through converging postsynaptic activation of MAP kinases. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 19(22): 9788-9802
Kram, M.L.; Kramer, G.L.; Ronan, P.J.; Steciuk, M.; Petty, F. 2002: Dopamine receptors and learned helplessness in the rat: An autoradiographic study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 26(4): 639-645
Sealfon, S.C. 2000: Dopamine receptors and locomotor responses: molecular aspects. Annals of Neurology 47(4 Suppl 1): S12
Tupala, E.; Hall, Håkan.; Mantere, T.; Räsänen, P.; Särkioja, T.; Tiihonen, J. 2003: Dopamine receptors and transporters in the brain reward circuits of type 1 and 2 alcoholics measured with human whole hemisphere autoradiography. NeuroImage 19(1): 145-155
Ricci, A.; Bronzetti, E.; Mannino, F.; Mignini, F.; Morosetti, C.; Tayebati, S.K.; Amenta, F. 2001: Dopamine receptors in human platelets. Naunyn-Schmiedeberg's Archives of Pharmacology 363(4): 376-382
Kestler, L.P.; Walker, E.; Vega, E.M. 2001: Dopamine receptors in the brains of schizophrenia patients: a meta-analysis of the findings. Behavioural Pharmacology 12(5): 355-371
Hemsley, K.M.; Farrall, E.J.; Crocker, A.D. 2002: Dopamine receptors in the subthalamic nucleus are involved in the regulation of muscle tone in the rat. Neuroscience Letters 317(3): 123-126
Sealfon, S.C.; Olanow, C.W. 2000: Dopamine receptors: from structure to behavior. Trends in Neurosciences 23(10 Suppl): S34-S40
Levein, N.G.; Thörn, S.E.; Lindberg, G.; Wattwill, M. 1999: Dopamine reduces gastric tone in a dose-related manner. Acta Anaesthesiologica Scandinavica 43(7): 722-725
Küppers, E.; Beyer, C. 2001: Dopamine regulates brain-derived neurotrophic factor (BDNF) expression in cultured embryonic mouse striatal cells. Neuroreport 12(6): 1175-1179
Magill, P.J.; Bolam, J.P.; Bevan, M.D. 2001: Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus-globus pallidus network. Neuroscience 106(2): 313-330
Han Gui Chun; Mcmillin, P.J.P.; White, R.E. 2000: Dopamine relaxes porcine coronary arteries and stimulates potassium channel activity in porcine coronary arterial smooth muscle cells. Zhongguo Yaolixue Yu Dulixue Zazhi 14(6): 421-424
Walker, Q.D.; Rooney, M.B.; Wightman, R.M.; Kuhn, C.M. 2000: Dopamine release and uptake are greater in female than male rat striatum as measured by fast cyclic voltammetry. Neuroscience 95(4): 1061-1070
Cragg, S.J.; Hille, C.J.; Greenfield, S.A. 2000: Dopamine release and uptake dynamics within nonhuman primate striatum in vitro. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 20(21): 8209-8217
Nurmi, M.; Sinclair, J.D.; Kiianmaa, K. 1998: Dopamine release during ethanol drinking in AA rats. Alcoholism Clinical and Experimental Research 22(8): 1628-1633
Goerendt, I.K.; Messa, C.; Lawrence, A.D.; Grasby, P.M.; Piccini, P.; Brooks, D.J. 2003: Dopamine release during sequential finger movements in health and Parkinson's disease: a PET study. Brain: a Journal of Neurology 126(Part 2): 312-325
Del Arco, A.; Segovia, G.; Mora, F. 2001: Dopamine release during stress in the prefrontal cortex of the rat decreases with age. Neuroreport 12(18): 4019-4022
Yavich, L.; Macdonald, E. 2000: Dopamine release from pharmacologically distinct storage pools in rat striatum following stimulation at frequency of neuronal bursting. Brain Research 870(1-2): 73-79
de la Fuente-Fernández, Rúl.; Phillips, A.G.; Zamburlini, M.; Sossi, V.; Calne, D.B.; Ruth, T.J.; Stoessl, A.Jon. 2002: Dopamine release in human ventral striatum and expectation of reward. Behavioural Brain Research 136(2): 359-363
Ito, R.; Dalley, J.W.; Robbins, T.W.; Everitt, B.J. 2002: Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 22(14): 6247-6253
Matuszewich, L.; Lorrain, D.S.; Hull, E.M. 2000: Dopamine release in the medial preoptic area of female rats in response to hormonal manipulation and sexual activity. Behavioral Neuroscience 114(4): 772-782
Del Arco, A.; Mora, F. 2001: Dopamine release in the prefrontal cortex during stress is reduced by the local activation of glutamate receptors. Brain Research Bulletin 56(2): 125-130
Hesselink, M.B.; De Boer, A.G.; Breimer, D.D.; Danysz, W. 1999: Dopamine release in the prefrontal cortex in response to memantine following sub-chronic NMDA receptor blockade with memantine: A microdialysis study in rats. Journal of Neural Transmission 106(9-10): 803-818
Hauber, W.; Fuchs, H. 2000: Dopamine release in the rat globus pallidus characterised by in vivo microdialysis. Behavioural Brain Research 111(1-2): 39-44
Junxia, X.; Hong, J.; Wenfang, C.; Ming, Q. 2003: Dopamine release rather than content in the caudate putamen is associated with behavioral changes in the iron rat model of Parkinson's disease. Experimental Neurology 182(2): 483-489
Heimer, G.; Bar-Gad, I.; Goldberg, J.A.; Bergman, H. 2002: Dopamine replacement therapy reverses abnormal synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of parkinsonism. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 22(18): 7850-7855
Zocchi, A.; Girlanda, E.; Varnier, G.; Sartori, I.; Zanetti, L.; Wildish, G.A.; Lennon, M.; Mugnaini, M.; Heidbreder, C.A. 2003: Dopamine responsiveness to drugs of abuse: a shell-core investigation in the nucleus accumbens of the mouse. Synapse 50(4): 293-302
Saldías, F.J.; Lecuona, E.; Comellas, A.P.; Ridge, K.M.; Sznajder, J.I. 1999: Dopamine restores lung ability to clear edema in rats exposed to hyperoxia. American Journal of Respiratory and Critical Care Medicine 159(2): 626-633
Hansard, M.J.; Smith, L.A.; Jackson, M.J.; Cheetham, S.C.; Jenner, P. 2002: Dopamine reuptake inhibition and failure to evoke dyskinesia in MPTP-treated primates. European Journal of Pharmacology 451(2): 157-160
Burkey, A.R.; Carstens, E.; Jasmin, L. 1999: Dopamine reuptake inhibition in the rostral agranular insular cortex produces antinociception. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 19(10): 4169-4179
Federici, M.; Natoli, S.; Bernardi, G.; Mercuri, N.B. 2002: Dopamine selectively reduces GABA(B) transmission onto dopaminergic neurones by an unconventional presynaptic action. Journal of Physiology 540(Pt 1): 119-128
Karasawa, F.; Okuda, T.; Tsutsui, M.; Matsuoka, N.; Yamada, S.; Kawatani, Y.; Satoh, T. 2003: Dopamine stabilizes milrinone-induced changes in heart rate and arterial pressure during anaesthesia with isoflurane. European Journal of Anaesthesiology 20(2): 120-123
Rohr, O.; Sawaya, B.E.; Lecestre, D.; Aunis, D.; Schaeffer, E. 1999: Dopamine stimulates expression of the human immunodeficiency virus type 1 via NF-kappaB in cells of the immune system. Nucleic Acids Research 27(16): 3291-3299
Luo, Y.; Kokkonen, G.C.; Hattori, A.; Chrest, F.J.; Roth, G.S. 1999: Dopamine stimulates redox-tyrosine kinase signaling and p38 MAPK in activation of astrocytic C6-D2L cells. Brain Research 850(1-2): 21-38
Grossman, M.; Glosser, G.; Kalmanson, J.; Morris, J.; Stern, M.B.; Hurtig, H.I. 2001: Dopamine supports sentence comprehension in Parkinson's disease. Journal of the Neurological Sciences 184(2): 123-130
Haskó, G.ör.; Szabó, C.; Németh, Z.án.H.; Deitch, E.A. 2002: Dopamine suppresses IL-12 p40 production by lipopolysaccharide-stimulated macrophages via a beta-adrenoceptor-mediated mechanism. Journal of Neuroimmunology 122(1-2): 34-39
Maher, B.S.; Marazita, M.L.; Ferrell, R.E.; Vanyukov, M.M. 2002: Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis. Psychiatric Genetics 12(4): 207-215
Carr, D.B.; O'Donnell, P.; Card, J.P.; Sesack, S.R. 1999: Dopamine terminals in the rat prefrontal cortex synapse on pyramidal cells that project to the nucleus accumbens. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 19(24): 11049-11060
Carr, D.B.; Sesack, S.R. 2000: Dopamine terminals synapse on callosal projection neurons in the rat prefrontal cortex. Journal of Comparative Neurology 425(2): 275-283
Johnson, J.R.; Robinson, B.L.; Ali, S.F.; Binienda, Z. 2000: Dopamine toxicity following long term exposure to low doses of 3-nitropropionic acid (3-NPA) in rats. Toxicology Letters 116(1-2): 113-118
Stokes, A.H.; Lewis, D.Y.; Lash, L.H.; Jerome, W.G.; Grant, K.W.; Aschner, M.; Vrana, K.E. 2000: Dopamine toxicity in neuroblastoma cells: Role of glutathione depletion by L-BSO and apoptosis. Brain Research 858(1): 1-8
Augood, S.J.; Hollingsworth, Z.; Albers, D.S.; Yang, L.; Leung, J.-C.; Muller, B.; Klein, C.; Breakefield, X.O.; Standaert, D.G. 2002: Dopamine transmission in DYT1 dystonia: a biochemical and autoradiographical study. Neurology 59(3): 445-448
Sulzer, D.; Galli, A. 2003: Dopamine transport currents are promoted from curiosity to physiology. Trends in Neurosciences 26(4): 173-176
Mash, D.C.; Pablo, J.; Ouyang, Q.; Hearn, W.Lee.; Izenwasser, S. 2002: Dopamine transport function is elevated in cocaine users. Journal of Neurochemistry 81(2): 292-300
Hamano, T.; Tsuchida, T.; Hirayama, M.; Fujiyama, J.; Mutoh, T.; Yonekura, Y.; Kuriyama, M. 2000: Dopamine transporter SPECT in patients with Parkinson's disease. Kaku Igaku. Japanese Journal of Nuclear Medicine 37(2): 125-129
Hoffman, A.F.; Lupica, C.R.; Gerhardt, G.A. 1998: Dopamine transporter activity in the substantia nigra and striatum assessed by high-speed chronoamperometric recordings in brain slices. Journal of Pharmacology and Experimental Therapeutics 287(2): 487-496
Cowell, R.M.; Kantor, L.; Hewlett, G.H.; Frey, K.A.; Gnegy, M.E. 2000: Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes. European Journal of Pharmacology 389(1): 59-65
Laine, T.P.; Ahonen, A.; Räsänen, P.; Tiihonen, J. 1999: Dopamine transporter availability and depressive symptoms during alcohol withdrawal. Psychiatry Research 90(3): 153-157
Müller-Vahl, K.R.; Berding, G.; Brücke, T.; Kolbe, H.; Meyer, G.J.; Hundeshagen, H.; Dengler, R.; Knapp, W.H.; Emrich, H.M. 2000: Dopamine transporter binding in Gilles de la Tourette syndrome. Journal of Neurology 247(7): 514-520
Huang, C-Chang.; Chu, N-Shin.; Yen, T-Chen.; Wai, Y-Yau.; Lu, C-Song. 2003: Dopamine transporter binding in Wilson's disease. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 30(2): 163-167
Anonymous 2002: Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. JAMA 287(13): 1653-1661
Yen, T-Chen.; Tzen, K-Yuan.; Chen, M-Chi.; Chou, Y-Huei.Wu.; Chen, R-Shayn.; Chen, C-Jen.; Wey, S-Pyng.; Ting, G.; Lu, C-Song. 2002: Dopamine transporter concentration is reduced in asymptomatic Machado-Joseph disease gene carriers. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 43(2): 153-159
Dougherty, D.D.; Bonab, A.A.; Spencer, T.J.; Rauch, S.L.; Madras, B.K.; Fischman, A.J. 1999: Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 354(9196): 2132-2133
Lavalaye, J.; Sarlet, A.; Booij, J.; Linszen, D.H.; Reneman, L.; Gersons, B.P.; van Royen, E.A. 2001: Dopamine transporter density in patients with tardive dyskinesia: a single photon emission computed tomography study. Psychopharmacology 155(1): 107-109
Holzschuh, J.; Ryu, S.; Aberger, F.; Driever, W. 2001: Dopamine transporter expression distinguishes dopaminergic neurons from other catecholaminergic neurons in the developing zebrafish embryo. Mechanisms of Development 101(1-2): 237-243
Van Kampen, J.M.; McGeer, E.G.; Stoessl, A.J. 2000: Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity. Synapse 37(3): 171-178
Georgieva, L.; Dimitrova, A.; Nikolov, I.; Koleva, S.; Tsvetkova, R.; Owen, M.J.; Toncheva, D.; Kirov, G. 2002: Dopamine transporter gene (DAT1) VNTR polymorphism in major psychiatric disorders: Family-based association study in the Bulgarian population. Acta Psychiatrica Scandinavica 105(5): 396-399
Roman, T.; Szobot, C.; Martins, S.; Biederman, J.; Rohde, L.A.; Hutz, M.H. 2002: Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder. Pharmacogenetics 12(6): 497-499
Rohde, L.A.; Roman, T.; Szobot, C.; Cunha, R.D.; Hutz, M.H.; Biederman, J. 2003: Dopamine transporter gene, response to methylphenidate and cerebral blood flow in attention-deficit/hyperactivity disorder: a pilot study. Synapse 48(2): 87-89
Lewis, D.A.; Melchitzky, D.S.; Sesack, S.R.; Whitehead, R.E.; Auh, S.; Sampson, A. 2001: Dopamine transporter immunoreactivity in monkey cerebral cortex: Regional, laminar, and ultrastructural localization. Journal of Comparative Neurology 432(1): 119-136
Caronti, B.; Antonini, G.; Calderaro, C.; Ruggieri, S.; Palladini, G.; Pontieri, F.E.; Colosimo, C. 2001: Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson's disease. Journal of Neural Transmission 108(7): 803-807
Bergström, K.A.; Tupala, E.; Tiihonen, J. 2001: Dopamine transporter in vitro binding and in vivo imaging in the brain. Pharmacology and Toxicology 88(6): 287-293
Fernagut, P-O.; Diguet, E.; Jaber, M.; Bioulac, B.; Tison, Fçois. 2002: Dopamine transporter knock-out mice are hypersensitive to 3-nitropropionic acid-induced striatal damage. European Journal of Neuroscience 15(12): 2053-2056
Eberling, J.L.; Bankiewicz, K.S.; Pivirotto, P.; Bringas, J.; Chen, K.; Nowotnik, D.P.; Steiner, J.P.; Budinger, T.F.; Jagust, W.J. 1999: Dopamine transporter loss and clinical changes in MPTP-lesioned primates. Brain Research 832(1-2): 184-187
Chen, L.; Segal, D.M.; Moraes, C.T.; Mash, D.C. 1999: Dopamine transporter mRNA in autopsy studies of chronic cocaine users. Brain Research. Molecular Brain Research 73(1-2): 181-185
Lin, Z.; Uhl, G.R. 2002: Dopamine transporter mutants with cocaine resistance and normal dopamine uptake provide targets for cocaine antagonism. Molecular Pharmacology 61(4): 885-891
Young, S.E.; Smolen, A.; Corley, R.P.; Krauter, K.S.; Defries, J.C.; Crowley, T.J.; Hewitt, J.K. 2002: Dopamine transporter polymorphism associated with externalizing behavior problems in children. American Journal of Medical Genetics 114(2): 144-149
Lin, Z.; Itokawa, M.; Uhl, G.R. 2000: Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 14(5): 715-728
Kimmel, H.L.; Carroll, F.I.; Kuhar, M.J. 2000: Dopamine transporter synthesis and degradation rate in rat striatum and nucleus accumbens using RTI-76. Neuropharmacology 39(4): 578-585
Itokawa, M.; Lin, Z.; Cai, N.S.; Wu, C.; Kitayama, S.; Wang, J.B.; Uhl, G.R. 2000: Dopamine transporter transmembrane domain polar mutants: DeltaG and Delta DeltaG values implicate regions important for transporter functions. Molecular Pharmacology 57(6): 1093-1103
Lin, Z.; Wang, W.; Uhl, G.R. 2000: Dopamine transporter tryptophan mutants highlight candidate dopamine- and cocaine-selective domains. Molecular Pharmacology 58(6): 1581-1592
Yatin, S.M.; Miller, G.M.; Norton, C.; Madras, B.K. 2002: Dopamine transporter-dependent induction of C-Fos in HEK cells. Synapse 45(1): 52-65
Melchitzky, D.S.; Lewis, D.A. 2001: Dopamine transporter-immunoreactive axons in the mediodorsal thalamic nucleus of the macaque monkey. Neuroscience 103(4): 1033-1042
Ma, S.Y.; Ciliax, B.J.; Stebbins, G.; Jaffar, S.; Joyce, J.N.; Cochran, E.J.; Kordower, J.H.; Mash, D.C.; Levey, A.I.; Mufson, E.J. 1999: Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigra. Journal of Comparative Neurology 409(1): 25-37
Lin, Z.; Wang, W.; Kopajtic, T.; Revay, R.S.; Uhl, G.R. 1999: Dopamine transporter: transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition. Molecular Pharmacology 56(2): 434-447
Foster, J.D.; Pananusorn, B.; Cervinski, M.A.; Holden, H.E.; Vaughan, R.A. 2003: Dopamine transporters are dephosphorylated in striatal homogenates and in vitro by protein phosphatase 1. Brain Research. Molecular Brain Research 110(1): 100-108
Foster, J.D.; Pananusorn, B.; Vaughan, R.A. 2002: Dopamine transporters are phosphorylated on N-terminal serines in rat striatum. Journal of Biological Chemistry 277(28): 25178-25186
Stamm, C.; Friehs, I.; Cowan, D.B.; Cao-Danh, H.; Choi, Y-Hoon.; Duebener, L.F.; McGowan, F.X.; del Nido, P.J. 2002: Dopamine treatment of postischemic contractile dysfunction rapidly induces calcium-dependent pro-apoptotic signaling. Circulation 106(12 Suppl 1): I290-I298
Melnikova, V.; Orosco, M.; Calas, A.; Sapronova, A.; Gainetdinov, R.; Delhaye-Bouchaud, N.; Nicolaidis, S.; Rayevsky, K.; Ugrumov, M. 1999: Dopamine turnover in the mediobasal hypothalamus in rat fetuses. Neuroscience 89(1): 235-241
Ho, M.; Segre, M. 2000: Dopamine uptake by mouse neuroblastoma N1E-115 cells stably expressing human dopamine transporter is differentially inhibited by anti-idiotypic ab2beta antibodies mimicking the configuration of cocaine. Brain Research 872(1-2): 231-235
Rabey, J.M.; Amir, I.; Treves, T.A.; Oberman, Z.; Korczyn, A.D. 1998: Dopamine uptake by platelet storage granules in first-degree relatives of Tourette's syndrome patients. Biological Psychiatry 44(11): 1166-1170
Morón, J.A.; Brockington, A.; Wise, R.A.; Rocha, B.A.; Hope, B.T. 2002: Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 22(2): 389-395
Mizoguchi, M.B.; Chu, T.G.; Murphy, F.M.; Willits, N.; Morse, L.S. 1999: Dopamine use is an indicator for the development of threshold retinopathy of prematurity. British Journal of Ophthalmology 83(4): 425-428
Basu, S.; Dasgupta, P.S. 2000: Dopamine, a neurotransmitter, influences the immune system. Journal of Neuroimmunology 102(2): 113-124
See, R.E.; Kruzich, P.J.; Grimm, J.W. 2001: Dopamine, but not glutamate, receptor blockade in the basolateral amygdala attenuates conditioned reward in a rat model of relapse to cocaine-seeking behavior. Psychopharmacology 154(3): 301-310
Hansard, M.J.; Smith, L.A.; Jackson, M.J.; Cheetham, S.C.; Jenner, P. 2002: Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates. Journal of Pharmacology and Experimental Therapeutics 303(3): 952-958
Buerk, D.G.; Osanai, S.; Mokashi, A.; Lahiri, S. 1998: Dopamine, sensory discharge, and stimulus interaction with CO2 and O2 in cat carotid body. Journal of Applied Physiology 85(5): 1719-1726
Kozicz, Tás.; Arimura, A. 2002: Dopamine- and cyclic AMP-regulated phosphoprotein-immunoreactive neurons activated by acute stress are innervated by fiber terminals immunopositive for pituitary adenylate cyclase-activating polypeptide in the extended amygdala in the rat. Regulatory Peptides 109(1-3): 63-70
Sanada, H.; Jose, P.A.; Hazen-Martin, D.; Yu, P.Y.; Xu, J.; Bruns, D.E.; Phipps, J.; Carey, R.M.; Felder, R.A. 1999: Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension 33(4): 1036-1042
Banihashemi, B.; Albert, P.R. 2002: Dopamine-D2S receptor inhibition of calcium influx, adenylyl cyclase, and mitogen-activated protein kinase in pituitary cells: distinct Galpha and Gbetagamma requirements. Molecular Endocrinology 16(10): 2393-2404
De Parada, M.P.; Parada, M.A.; Rada, P.; Hernandez, L.; Hoebel, B.G. 2000: Dopamine-acetylcholine interaction in the rat lateral hypothalamus in the control of locomotion. Pharmacology Biochemistry and Behavior 66(2): 227-234
Kim, D.S.; Szczypka, M.S.; Palmiter, R.D. 2000: Dopamine-deficient mice are hypersensitive to dopamine receptor agonists. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 20(12): 4405-4413
Arai, R.; Horiike, K.; Hasegawa, Y. 1998: Dopamine-degrading activity of monoamine oxidase is not detected by histochemistry in neurons of the substantia nigra pars compacta of the rat. Brain Research 812(1-2): 275-278
Williams, D.; Tijssen, M.; Van Bruggen, G.; Bosch, A.; Insola, A.; Di Lazzaro, V.; Mazzone, P.; Oliviero, A.; Quartarone, A.; Speelman, H.; Brown, P. 2002: Dopamine-dependent changes in the functional connectivity between basal ganglia and cerebral cortex in humans. Brain: a Journal of Neurology 125(Part 7): 1558-1569
Choi, H.Jin.; Kim, S.Who.; Lee, S.Yeon.; Hwang, O. 2003: Dopamine-dependent cytotoxicity of tetrahydrobiopterin: A possible mechanism for selective neurodegeneration in Parkinson's disease. Journal of Neurochemistry 86(1): 143-152
Kim, D.S.; Froelick, G.J.; Palmiter, R.D. 2002: Dopamine-dependent desensitization of dopaminergic signaling in the developing mouse striatum. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 22(22): 9841-9849
Chartoff, E.H.; Papadopoulou, M.; Konradi, C.; Carlezon, W.A. 2003: Dopamine-dependent increases in phosphorylation of cAMP response element binding protein (CREB) during precipitated morphine withdrawal in primary cultures of rat striatum. Journal of Neurochemistry 87(1): 107-118
Reynolds, J.N.J.; Wickens, J.R. 2002: Dopamine-dependent plasticity of corticostriatal synapses. Neural Networks: the Official Journal of the International Neural Network Society 15(4-6): 507-521
Lu, L.; Liu, Z.; Huang, M.; Zhang, Z. 2003: Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes. Journal of Neurochemistry 84(6): 1378-1386
Suzuki, T.; Miura, M.; Nishimura, K.; Aosaki, T. 2001: Dopamine-dependent synaptic plasticity in the striatal cholinergic interneurons. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 21(17): 6492-6501
Naoi, M.; Maruyama, W.; Akao, Y.; Yi, H. 2002: Dopamine-derived endogenous N-methyl-(R)-salsolinol: Its role in Parkinson's disease. Neurotoxicology and Teratology 24(5): 579-591
Kiyatkin, E.A.; Rebec, G.V. 2000: Dopamine-independent action of cocaine on striatal and accumbal neurons. European Journal of Neuroscience 12(5): 1789-1800
Cornish, J.L.; Nakamura, M.; Kalivas, P.W. 2001: Dopamine-independent locomotion following blockade of N-methyl-D-aspartate receptors in the ventral tegmental area. Journal of Pharmacology and Experimental Therapeutics 298(1): 226-233
Jones, D.C.; Gunasekar, P.G.; Borowitz, J.L.; Isom, G.E. 2000: Dopamine-induced apoptosis is mediated by oxidative stress and is enhanced by cyanide in differentiated PC12 cells. Journal of Neurochemistry 74(6): 2296-2304
Chibalin, A.V.; Ogimoto, G.; Pedemonte, C.H.; Pressley, T.A.; Katz, A.I.; Féraille, E.; Berggren, P.O.; Bertorello, A.M. 1999: Dopamine-induced endocytosis of Na+,K+-ATPase is initiated by phosphorylation of Ser-18 in the rat alpha subunit and Is responsible for the decreased activity in epithelial cells. Journal of Biological Chemistry 274(4): 1920-1927
Ridge, K.M.; Dada, L.; Lecuona, E.; Bertorello, A.M.; Katz, A.I.; Mochly-Rosen, D.; Sznajder, J.I. 2002: Dopamine-induced exocytosis of Na,K-ATPase is dependent on activation of protein kinase C-epsilon and -delta. Molecular Biology of the Cell 13(4): 1381-1389
Grima, G.; Benz, B.; Parpura, V.; Cuénod, M.; Do, K.Q. 2003: Dopamine-induced oxidative stress in neurons with glutathione deficit: Implication for schizophrenia. Schizophrenia Research 62(3): 213-224
Nowicki, S.; Kruse, M.S.; Brismar, H.; Aperia, A. 2000: Dopamine-induced translocation of protein kinase C isoforms visualized in renal epithelial cells. American Journal of Physiology. Cell Physiology 279(6): C1812-C1818
Gerfen, C.R. 2000: Dopamine-mediated gene regulation in models of Parkinson's disease. Annals of Neurology 47(4 Suppl 1): S42
Banday, A.A.; Asghar, M.; Hussain, T.; Lokhandwala, M.F. 2003: Dopamine-mediated inhibition of renal Na,K-ATPase is reduced by insulin. Hypertension 41(6): 1353-1358
Onn, S.P.; West, A.R.; Grace, A.A. 2000: Dopamine-mediated regulation of striatal neuronal and network interactions. Trends in Neurosciences 23(10 Suppl): S48-S56
Durstewitz, D.; Seamans, J.K.; Sejnowski, T.J. 2000: Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex. Journal of Neurophysiology 83(3): 1733-1750
Cragg, S.J.; Nicholson, C.; Kume-Kick, J.; Tao, L.; Rice, M.E. 2001: Dopamine-mediated volume transmission in midbrain is regulated by distinct extracellular geometry and uptake. Journal of Neurophysiology 85(4): 1761-1771
Offen, D.; Gorodin, S.; Melamed, E.; Hanania, J.; Malik, Z. 1999: Dopamine-melanin is actively phagocytized by PC12 cells and cerebellar granular cells: Possible implications for the etiology of Parkinson's disease. Neuroscience Letters 260(2): 101-104
Stepień, K.; Zajdel, A.; Wilczok, A.; Wilczok, T.; Grzelak, A.; Mateja, A.; Soszyński, M.; Bartosz, G. 2000: Dopamine-melanin protects against tyrosine nitration, tryptophan oxidation and Ca(2+)-ATPase inactivation induced by peroxynitrite. Biochimica et Biophysica Acta 1523(2-3): 189-195
Mavridis, M.; Besson, M.J. 1999: Dopamine-opiate interaction in the regulation of neostriatal and pallidal neuronal activity as assessed by opioid precursor peptides and glutamate decarboxylase messenger RNA expression. Neuroscience 92(3): 945-966
Unterwald, E.M.; Cuntapay, M. 2000: Dopamine-opioid interactions in the rat striatum: A modulatory role for dopamine D1 receptors in delta opioid receptor-mediated signal transduction. Neuropharmacology 39(3): 372-381
Mizoguchi, K.; Yuzurihara, M.; Nagata, M.; Ishige, A.; Sasaki, H.; Tabira, T. 2002: Dopamine-receptor stimulation in the prefrontal cortex ameliorates stress-induced rotarod impairment. Pharmacology Biochemistry and Behavior 72(3): 723-728
Calon, F.; Hadj Tahar, A.; Blanchet, P.J.; Morissette, M.; Grondin, R.; Goulet, M.; Doucet, J.P.; Robertson, G.S.; Nestler, E.; Di Paolo, T.; Bédard, P.J. 2000: Dopamine-receptor stimulation: biobehavioral and biochemical consequences. Trends in Neurosciences 23(10 Suppl): S92-S100
Sy, C.; Airriess, C.N. 2002: Dopamine-stimulated limb autotomy in the Dungeness crab, Cancer magister. Journal of Crustacean Biology 22(4): 697-703
Szczypka, M.S.; Zhou, Q.Y.; Palmiter, R.D. 1998: Dopamine-stimulated sexual behavior is testosterone dependent in mice. Behavioral Neuroscience 112(5): 1229-1235
Tupala, E.; Hall, H.; Särkioja, T.; Räsänen, P.; Tiihonen, J. 2000: Dopamine-transporter density in nucleus accumbens of type-1 alcoholics. Lancet 355(9201): 380
Gatley, S.J.; Volkow, N.D.; Gifford, A.N.; Fowler, J.S.; Dewey, S.L.; Ding, Y.S.; Logan, J. 1999: Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans. Psychopharmacology 146(1): 93-100
Xu, J.; Li, X.X.; Albrecht, F.E.; Hopfer, U.; Carey, R.M.; Jose, P.A. 2000: Dopamine(1) receptor, G(salpha), and Na(+)-H(+) exchanger interactions in the kidney in hypertension. Hypertension 36(3): 395-399
Kakade, S.; Dayan, P. 2002: Dopamine: Generalization and bonuses. Neural Networks: the Official Journal of the International Neural Network Society 15(4-6): 549-559
Lehmann, T.; Hübner, H.; Gmeiner, P. 2001: Dopaminergic 7-aminotetrahydroindolizines: Ex-chiral pool synthesis and preferential D3 receptor binding. Bioorganic and Medicinal Chemistry Letters 11(21): 2863-2866
Fumagalli, F.; Bedogni, F.; Maragnoli, M.E.; Gennarelli, M.; Perez, J.; Racagni, G.; Riva, M.A. 2003: Dopaminergic D2 receptor activation modulates FGF-2 gene expression in rat prefrontal cortex and hippocampus. Journal of Neuroscience Research 74(1): 74-80
Lin, J.Y.; Lipski, J. 2001: Dopaminergic substantia nigra neurons express functional nmda receptors in postnatal rats. Journal of Neurophysiology 85(3): 1336-1339
Klimek, V.; Schenck, J.E.; Han, H.; Stockmeier, C.A.; Ordway, G.A. 2002: Dopaminergic abnormalities in amygdaloid nuclei in major depression: A postmortem study. Biological Psychiatry 52(7): 740-748
Piggott, M.A.; Marshall, E.F.; Thomas, N.; Lloyd, S.; Court, J.A.; Jaros, E.; Costa, D.; Perry, R.H.; Perry, E.K. 1999: Dopaminergic activities in the human striatum: Rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine. Neuroscience 90(2): 433-445
Cyr, M.; Morissette, M.; Barden, N.; Beaulieu, S.; Rochford, J.; Di Paolo, T. 2001: Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: Effect of antidepressants. Neuroscience 102(1): 151-158
Relja, M.; Klepac, N.; Subotic, Z. 2002: Dopaminergic agonist and cognitive function in Parkinson's disease. Periodicum Biologorum 104(1): 43-45
Bina, K.G.; Cincotta, A.H. 2000: Dopaminergic agonists normalize elevated hypothalamic neuropeptide y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice. Neuroendocrinology 71(1): 68-78
Fujieda, H.; Scher, J.; Hamadanizadeh, S.A.; Wankiewicz, E.; Pang, S.F.; Brown, G.M. 2000: Dopaminergic and GABAergic amacrine cells are direct targets of melatonin: immunocytochemical study of mt1 melatonin receptor in guinea pig retina. Visual Neuroscience 17(1): 63-70
Besheer, J.; Short, K.R.; Bevins, R.A. 2001: Dopaminergic and cholinergic antagonism in a novel-object detection task with rats. Behavioural Brain Research 126(1-2): 211-217
Desai, R.I.; Barber, D.J.; Terry, P. 2003: Dopaminergic and cholinergic involvement in the discriminative stimulus effects of nicotine and cocaine in rats. Psychopharmacology 167(4): 335-343
Coiro, V.; Volpi, R.; Cataldo, S.; Capretti, L.; Caffarri, G.; Pilla, S.; Chiodera, P. 2000: Dopaminergic and cholinergic involvement in the inhibitory effect of dexamethasone on the TSH response to TRH. Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research 48(2): 133-136
Adachi, K.; Hasegawa, M.; Fujita, S.; Sato, M.; Miwa, Y.; Ikeda, H.; Koshikawa, N.; Cools, A.R. 2002: Dopaminergic and cholinergic stimulation of the ventrolateral striatum elicit rat jaw movements that are funnelled via distinct efferents. European Journal of Pharmacology 442(1-2): 81-92
Besson, A.; Privat, A.M.; Eschalier, A.; Fialip, J. 1999: Dopaminergic and opioidergic mediations of tricyclic antidepressants in the learned helplessness paradigm. Pharmacology Biochemistry and Behavior 64(3): 541-548
Benedetti, F.; Campori, E.; Barbini, B.; Fulgosi, M.C.; Colombo, C. 2001: Dopaminergic augmentation of sleep deprivation effects in bipolar depression. Psychiatry Research 104(3): 239-246
Chun, H.S.; Gibson, G.E.; Degiorgio, L.A.; Zhang, H.; Kidd, V.J.; Son, J.H. 2001: Dopaminergic cell death induced by MPP(+), oxidant and specific neurotoxicants shares the common molecular mechanism. Journal of Neurochemistry 76(4): 1010-1021
He, Y.; Thong, P.S.; Lee, T.; Leong, S.K.; Mao, B.Y.; Dong, F.; Watt, F. 2003: Dopaminergic cell death precedes iron elevation in MPTP-injected monkeys. Free Radical Biology and Medicine 35(5): 540-547
François, C.; Yelnik, J.; Tandé, D.; Agid, Y.; Hirsch, E.C. 1999: Dopaminergic cell group A8 in the monkey: Anatomical organization and projections to the striatum. Journal of Comparative Neurology 414(3): 334-347
Klein, R.L.; King, M.A.; Hamby, M.E.; Meyer, E.M. 2002: Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra. Human Gene Therapy 13(5): 605-612
Toledo-Aral, J.José.; Méndez-Ferrer, Són.; Pardal, R.; López-Barneo, Jé. 2002: Dopaminergic cells of the carotid body: Physiological significance and possible therapeutic applications in Parkinson's disease. Brain Research Bulletin 57(6): 847-853
Kish, S.J.; Kalasinsky, K.S.; Schmunk, G.; Furukawa, Y.; Guttman, M.; Ang, L. 2001: Dopaminergic changes in human brain following acute exposure to gamma-hydroxybutyrate. Neurology 56(11): 1602-1603
Antal, A.; Kéri, S.; Kincses, Z.T.ás.; Dibó, G.; Szabó, A.; Benedek, G.; Janka, Z.; Vécsei, L. 2003: Dopaminergic contributions to the visual categorization of natural scenes: evidence from Parkinson's disease. Journal of Neural Transmission 110(7): 757-770
Sansoè, G.; Ferrari, A.; Baraldi, E.; Castellana, C.Nives.; Biava, A.; Silvano, S.; Rosina, F.; Bonardi, L.; Manenti, F. 2002: Dopaminergic control of renal tubular function in patients with compensated cirrhosis. Digestive Diseases and Sciences 47(2): 392-400
Centonze, D.; Picconi, B.; Gubellini, P.; Bernardi, G.; Calabresi, P. 2001: Dopaminergic control of synaptic plasticity in the dorsal striatum. European Journal of Neuroscience 13(6): 1071-1077
Kostrzewa, R.M.; Kostrzewa, J.P.; Brus, R. 2000: Dopaminergic denervation enhances susceptibility to hydroxyl radicals in rat neostriatum. Amino Acids 19(1): 183-199
Honey, G.D.; Suckling, J.; Zelaya, F.; Long, C.; Routledge, C.; Jackson, S.; Ng, V.; Fletcher, P.C.; Williams, S.C.R.; Brown, J.; Bullmore, E.T. 2003: Dopaminergic drug effects on physiological connectivity in a human cortico-striato-thalamic system. Brain: a Journal of Neurology 126(Part 8): 1767-1781